These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¨
|
Preliminary Proxy Statement
|
|
¨
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
ý
|
Definitive Proxy Statement
|
|
¨
|
Definitive Additional Materials
|
|
¨
|
Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12
|
|
ý
|
No fee required.
|
|
¨
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
1)
|
Title of each class of securities to which transaction applies:
|
|
2)
|
Aggregate number of securities to which transaction applies:
|
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
5)
|
Total fee paid:
|
|
¨
|
Fee paid previously with preliminary materials.
|
|
¨
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
1)
|
Amount Previously Paid:
|
|
2)
|
Form, Schedule or Registration Statement No.:
|
|
3)
|
Filing Party:
|
|
4)
|
Date Filed:
|
|
1.
|
To elect eight (8) directors to serve until the next annual meeting of stockholders or until their respective successors have been duly elected and qualified;
|
|
2.
|
To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accountants for the fiscal year ending December 31, 2013;
|
|
3.
|
To conduct an advisory (non-binding) vote to approve the compensation of our named executive officers;
|
|
4.
|
To approve our amended and restated 2005 Incentive Plan; and
|
|
5.
|
To consider such other business as may properly come before the Annual Meeting of Stockholders or any adjournments or postponements thereof.
|
|
ALIGN TECHNOLOGY, INC.
|
|
|
|
|
Roger E. George
|
|
Vice President, Corporate and Legal Affairs, General
|
|
Counsel and Corporate Secretary and Interim Chief Financial Officer
|
|
TABLE OF CONTENTS
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q:
|
Why am I receiving these materials?
|
|
A:
|
Our Board of Directors (the “Board”) is providing these materials to you in connection with the solicitation of proxies for use at Align’s 2013 Annual Meeting of stockholders, which will take place on Thursday, May 16, 2013 at 10:00 a.m. local time, at our corporate headquarters located at 2560 Orchard Parkway, San Jose, California 95131 (referred to in this proxy statement as the “Annual Meeting”). As a stockholder, you are invited to attend the Annual Meeting and are requested to vote on the items of business described in this proxy statement.
|
|
Q:
|
What information is contained in these materials?
|
|
A:
|
This proxy statement contains important information regarding our Annual Meeting. Specifically, it identifies the proposals on which you are being asked to vote, provides information you may find useful in determining how to vote and describes the voting procedures. Align’s 2012 Annual Report on Form 10-K, proxy card and return envelope are also enclosed. These proxy materials are being mailed on or about April 18, 2013 to all of our stockholders as of the record date, which was set by our Board as March 22, 2013.
This proxy statement and Align’s annual report to stockholders for the fiscal year ended December 31, 2012 are available at www.aligntech.com by clicking on “Investor” and then clicking on “Click here for 2013 Annual Meeting/Proxy Materials.”
|
|
Q:
|
What proposals will be voted on at the Annual Meeting?
|
|
A:
|
The proposals that will be presented at the Annual Meeting and our Board’s voting recommendations are set forth in the table below:
|
|
Proposal
|
|
Board’s Voting
Recommendation
|
|
|
|
|
|
Proposal 1
—The election of eight (8) directors to serve until the next annual meeting of stockholders or until their respective successors have been duly elected and qualified.
|
|
For Each Director Nominee
|
|
|
|
|
|
Proposal 2
—The ratification of the appointment of PricewaterhouseCoopers LLP (“PwC”) as our independent registered public accountants for the fiscal year ending December 31, 2013.
|
|
For
|
|
|
|
|
|
Proposal 3
—An advisory vote to approve the compensation of our named executive officers.
|
|
For
|
|
|
|
|
|
Proposal 4
—Approval of Align's amended and restated 2005 Incentive Plan.
|
|
For
|
|
Q:
|
Who can attend the Annual Meeting?
|
|
A:
|
All stockholders as of the record date, or their duly appointed proxies, may attend the Annual Meeting. Registration will begin at 9:30 a.m. If you attend, please know that you may be asked to present valid picture identification, such as a driver’s license or passport. Stockholders holding stock in brokerage accounts (“street name” holders) will need to bring a copy of a brokerage statement reflecting stock ownership as of the record date. Cameras, recording devices and other electronic devices will not be permitted at the Annual Meeting.
|
|
Q:
|
Who can vote at the Annual Meeting?
|
|
A:
|
If you are a stockholder of record or a beneficial owner who owned our common stock at the close of business on March 22, 2013, the record date for the Annual Meeting, you are entitled to vote at the Annual Meeting. As of the record
|
|
Q:
|
What is the difference between holding shares directly or as a beneficial owner, in street name?
|
|
A:
|
Most of our shareholders hold their shares as a beneficial owner through a brokerage firm, bank or other nominee. As summarized below, there are some differences between shares held of record and those owned beneficially.
|
|
Q:
|
How do I vote?
|
|
A:
|
Voting by Mail
. Stockholders of record may submit a proxy by completing, signing, dating and returning the enclosed proxy card. Proxy cards submitted by mail must be received prior to the closing of the polls at the Annual Meeting in order for the votes to be recorded. By submitting a proxy card, you are authorizing our President and Chief Executive Officer and our Vice President, Corporate and Legal Affairs, General Counsel and Corporate Secretary, who are named on the proxy card as “proxies and attorneys-in-fact,” to vote your shares at the Annual Meeting in the manner you indicate.
|
|
Q:
|
What if I don’t give specific voting instructions?
|
|
A:
|
In the election of directors and for each other item, you may vote “FOR,” “AGAINST” or “ABSTAIN.” A vote of “ABSTAIN” with respect to any such matter will not be voted, although it will be counted for purposes of determining whether there is a quorum. Accordingly, an abstention will have the effect of a negative vote.
|
|
Q:
|
Can I change or revoke my vote?
|
|
A:
|
Subject to any rules your broker or other nominee may have, you may change your proxy instructions at any time before your proxy is voted at the Annual Meeting.
|
|
•
|
Sign and return another proxy bearing a later date prior to the time we take the vote at the Annual Meeting;
|
|
•
|
Submit a timely and valid Internet or telephone vote on a later date but prior to the time we take the vote at the Annual Meeting;
|
|
•
|
provide written notice of the revocation to:
|
|
•
|
attend the Annual Meeting and vote in person. Your attendance at the Annual Meeting will not cause your previously granted proxy to be revoked unless you specifically so request.
|
|
•
|
submit new voting instructions to your broker or other nominee; or
|
|
•
|
if you have obtained a legal proxy from your broker or other nominee giving you the right to vote your shares at the Annual Meeting, attend the Annual Meeting and vote in person.
|
|
Q:
|
What vote is required to approve each item?
|
|
A:
|
The vote required and the way the vote is calculated for the proposals is as follows:
|
|
PROPOSAL
|
|
VOTE REQUIRED
|
|
BROKER
DISCRETIONARY
VOTING ALLOWED
|
|
Proposal 1
—To Elect Directors
|
|
A nominee must receive more "for" votes than "against" votes and the number of votes "for" must be the majority of the required quorum
|
|
NO
|
|
|
|
|
||
|
Proposal 2
—To Ratify the Appointment of PwC as the Company’s Independent Registered Public Accounting Firm For Fiscal 2013
|
|
Majority of Shares Entitled to Vote and Present in Person or Represented by Proxy
|
|
YES
|
|
|
|
|
||
|
Proposal 3
—To Consider an Advisory Vote to Approve the Compensation of our Named Executive Officers
|
|
Majority of Shares Entitled to Vote and Present in Person or Represented by Proxy
|
|
NO
|
|
|
|
|
|
|
|
Proposal 4
—
To Approve Align's Amended and Restated 2005 Incentive Plan
|
|
Majority of Shares Entitled to Vote and Present in Person or Represented by Proxy
|
|
NO
|
|
Q:
|
What constitutes a quorum?
|
|
A:
|
A quorum, which is a majority of the outstanding shares of our common stock as of the record date, must be present or represented by proxy in order to hold the Annual Meeting and to conduct business. As of the record date, 81,724,618
shares of common stock, representing the same number of votes, were outstanding. That means that we need the holders of at least 81,724,618 shares of common stock to be represented for us to have a quorum. Your shares will be counted as present at the Annual Meeting if you attend the Annual Meeting in person. Your shares will be considered present and represented by proxy if you submit a properly executed proxy card or vote via the Internet or by telephone. Under the General Corporation Law of the State of Delaware, abstentions and broker “non-votes” are counted as present and entitled to vote and so are included for purposes of determining whether a quorum is present at the Annual Meeting.
|
|
Q:
|
Who will bear the cost of soliciting votes for the Annual Meeting?
|
|
A:
|
We will bear the entire cost of proxy solicitation, including the preparation, assembly, printing and mailing of proxy materials. The original solicitation of proxies by mail may be supplemented by solicitation by telephone and other means by directors, and employees of Align. None of these officers, directors or employees will receive special compensation for such services. In addition, we may reimburse brokerage firms and other custodians for their reasonable out-of-pocket expenses for forwarding these proxy materials to you. We have retained Alliance Advisors, LLC for an estimated fee of $11,500, plus out of pocket expenses, to assist in distributing proxy materials and soliciting proxies.
|
|
Q:
|
Who will count the vote?
|
|
A:
|
We expect a representative from Computershare Limited will tabulate the proxies and act as inspector of the election.
|
|
Q:
|
What if multiple stockholders share the same address?
|
|
A:
|
To reduce expenses, in some cases, we are delivering one set of voting materials to certain stockholders who share a single address, unless otherwise requested by one of the stockholders. A separate proxy card is included in the voting materials for each of these stockholders. If you have only received one set, you may request separate copies of the voting materials at no additional cost to you by calling us at (408) 470-1000 or by writing to us at Align Technology, Inc., 2560 Orchard Parkway, San Jose, California 95131, Attn: Investor Relations. You may also contact us by calling or writing if you would like to receive separate materials for future annual meetings.
|
|
Q:
|
What is the company’s website address?
|
|
A.
|
Our website address is
www.aligntech.com.
We make this proxy statement, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended available on our website in the Investor Relations section, as soon as reasonably practicable after electronically filing such material with the Securities and Exchange Commission (“SEC”).
|
|
Q:
|
Where can I find the voting results of the meeting?
|
|
A:
|
The preliminary results will be announced at the Annual Meeting. The final results will be published in a Current Report on Form 8-K, which we will file with the SEC by May 22, 2013.
|
|
Q:
|
Is there any information that I should know regarding future annual meetings?
|
|
A:
|
Stockholder proposals may be included in our proxy statement for an annual meeting so long as they are provided to us on a timely basis and satisfy the other conditions set forth in SEC regulations under Rule 14a-8 regarding the inclusion of stockholder proposals in company-sponsored proxy materials. For a stockholder proposal to be considered for inclusion in our proxy statement for the annual meeting to be held in 2014, we must receive the proposal at our principal executive offices, addressed to the Corporate Secretary, no later than January 1, 2014. In addition, a stockholder proposal that is not intended for inclusion in our proxy statement under Rule 14a-8 may be brought before the 2014 annual meeting so long as we receive information and notice of the proposal in compliance with the requirements set forth in our Bylaws, addressed to the Corporate Secretary at our principal executive offices, not later than February 15, 2014 nor earlier than January 16, 2014.
|
|
David E. Collins
Age: 78
Director since 2003
Board committees:
Audit and Compensation
|
|
Mr. Collins has served as a director of Align since April 2003. From 1994 to April 2004, Mr. Collins served as an independent consultant. His most recent operational role was with Schering-Plough Corporation from 1989 to 1994. At Schering-Plough, he created and served as president of a new consumer products division known as HealthCare Products, as well as serving as a member of the Schering-Plough Operations Committee, that company’s senior executive management group. Prior to Schering-Plough, Mr. Collins helped found New York-based venture capital firm Galen Partners. Mr. Collins also spent 26 years with Johnson & Johnson and from 1962 to 1978 he served in a number of roles in the legal department at Johnson & Johnson, including corporate secretary and general counsel. In 1978, Mr. Collins transitioned into a series of executive management roles, including President of McNeil Laboratories, with responsibility for several Latin American subsidiaries, leadership of the worldwide consumer products business and oversight of corporate public relations, investor relations, strategic planning and the government legislative liaison office. In 1982, Mr. Collins became a member of the Johnson & Johnson executive management committee. Mr. Collins also served on the board of directors of Johnson & Johnson and left in 1988 as vice chairman of that board.
For the following reasons, the Board concluded that Mr. Collins should serve as a director of Align. Mr. Collins has more than 30 years of business experience in the health care and consumer health products industry. Mr. Collins has demonstrated success in his business and leadership skills, serving as President of Schering-Plough’s HealthCare Products division and McNeil Laboratories and on the executive management committee at Johnson & Johnson. With this prior experience, Mr. Collins has considerable knowledge of the complex issues facing global companies and an understanding of what makes businesses work effectively and efficiently. Mr. Collins’ experience as a board member of Johnson & Johnson gives him insight and perspective into how other boards function and enables him to be an effective Board member. Mr. Collins’ strong legal background, including teaching courses on ethics and governance, makes him well-suited for our Compensation Committee. In addition, his finance and investment experience make him well-suited for our Audit Committee.
|
|
Joseph Lacob
Age: 57
Director since 1997
Board committees:
Nominating and Governance (Chair) and Technology
|
|
Mr. Lacob has served as a director of Align since August 1997 and has been a partner of Kleiner Perkins Caufield & Byers (KPCB), a venture capital firm, since May 1987. In 2011, Mr. Lacob acquired The Golden State Warriors of the National Basketball Association. He is currently the Managing Partner and CEO of the Warriors. Prior to joining KPCB in 1987, Mr. Lacob was an executive with Cetus Corporation (now Chiron), FHP International, a health maintenance organization, and the management consulting firm of Booz, Allen & Hamilton. He was previously on the board of directors of Orexigen Therapeutics, a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity and eHealth Inc., an online source of health insurance for individuals, families and small businesses. Mr. Lacob received his B.S. in Biological Sciences from the University of California at Irvine, his Masters in Public Health from the University of California at Los Angeles and his M.B.A. from Stanford University
For the following reasons, the Board concluded that Mr. Lacob should serve as a director of Align. Mr. Lacob has demonstrated success in his business and leadership skills, serving as a partner of KPCB since 1987. In his role at KPCB, he has gained considerable technology, health care and life sciences industry experience. During his career at KPCB, Mr. Lacob has been closely involved with investments in over fifty life science companies, including the start-up or incubation of a dozen ventures, and with KPCB's medical technology practice, which includes over thirty therapeutic and diagnostic medical device companies. With this extensive business background, Mr. Lacob also brings considerable finance and investment experience that has proven to be valuable in addressing issues that arise at Align.
|
|
C. Raymond Larkin Jr.
(Chairman of the Board)
Age: 64
Director since 2004
Board committees:
Nominating and Governance
|
|
Mr. Larkin has served as a director of Align since March 2004. In February 2006, Mr. Larkin was appointed as chairman of the Board. He currently is a Principal of Group Outcome L.L.C., a merchant banking firm concentrating on medical technologies. From 2001 to 2007, he served as a part time Venture Partner at Cutlass Capital, a venture capital firm. Mr. Larkin was previously chairman and chief executive officer at Eunoe, Inc., a medical device company. From 1983 to March 1998, he held various executive positions with Nellcor Puritan Bennett, Inc., a medical instrumentation company, for which he served as president and chief executive officer from 1989 until 1998. Mr. Larkin also held various positions of increasing responsibility at Bentley Laboratories/American Hospital Supply from 1976 to 1983. He serves on the board of directors of Heartware, Inc., a medical device company developing implant devices for the treatment of advanced heart failure. He previously served on the board of directors of Davita Inc., and Hangar Orthopedic Inc. Mr. Larkin received his B.S. in Industrial Management from LaSalle University.
For the following reasons, the Board concluded that Mr. Larkin should serve as a director of Align. Mr. Larkin brings with him considerable business experience in the medical device industry serving as President and CEO of a large public company. In his role as President and CEO of Nellcor Puritan Bennett, Inc., Mr. Larkin took on significant management, strategic and operational responsibilities leading that business through significant growth, including numerous mergers & acquisitions. This operational experience has proven valuable in addressing issues that have arisen at Align. With his knowledge of the medical device and health care industry, Mr. Larkin provides valuable insight to our Board. Mr. Larkin’s experience as a member of the board of directors of various public companies provides Mr. Larkin a deep understanding of the role of the board of directors and positions him well to serve as our Chairman.
|
|
|
|
|
|
George J. Morrow
Age: 61
Director since 2006
Board committees:
Compensation (Chair)
|
|
Mr. Morrow has served as a director of Align since February 2006. From February 2011 until January 2013, Mr. Morrow served as a consultant to Amgen Inc., a global biotechnology company. From 2003 until his retirement in February 2011, he was the executive vice president, global commercial operations at Amgen Inc., where he also served as executive vice president of worldwide sales and marketing between 2001 and 2003. From 1992 to 2001, Mr. Morrow held multiple leadership positions at GlaxoSmithKline Inc. and its subsidiaries, including president and chief executive officer of Glaxo Wellcome Inc. He is a member of the board of directors of Vical Incorporated, a company that researches and develops biopharmaceutical products and was a member of the board of directors of Human Genome Sciences, Inc., a biopharmaceutical discovery and development company, from March 2011 until its acquisition in August 2012 by GlaxoSmithKline plc.
Mr. Morrow holds a B.S. in Chemistry from Southampton College, Long Island University, an M.S. in Biochemistry from Bryn Mawr College and an M.B.A. from Duke University.
For the following reasons, the Board concluded that Mr. Morrow should serve as a director of Align. As a former executive vice president at Amgen and Glaxo, two large public companies, Mr. Morrow brings to our Board considerable business experience in the medical technology industry. As part of the executive leadership at Amgen, Mr. Morrow has recent front-line exposure to many of the issues facing public companies today, particularly on the operational, regulatory, financial and corporate governance fronts. Mr. Morrow's leadership skills and experience make him knowledgeable of the complex issues facing global companies today and give him an understanding of what makes businesses work effectively and efficiently. These skills and experience are extremely valuable to our Board and enable Mr. Morrow to be an effective Compensation Committee chairman.
|
|
Dr. David C. Nagel
Age: 67
Director since 2009
Board committees:
Compensation and
Technology (Chair)
|
|
Dr. David C. Nagel has served as a director of Align since July 2009. Dr. Nagel was president and CEO of PalmSource from 2001 to 2005, now known as ACCESS Systems Americas, Inc., a subsidiary of ACCESS which develops the Palm OS PDA operating system. Dr. Nagel also served as a member of the Palm board of directors. Prior to joining Palm, Dr. Nagel was the chief technology officer at AT&T and president of AT&T Labs from 1996 to 2001. Earlier in his career, Dr. Nagel was senior vice president at Apple Computer where he led the worldwide research and development group responsible for Mac OS software, Macintosh hardware, imaging and other peripheral products development. Before joining Apple, Dr. Nagel was head of NASA human factors research at NASA's Ames Research Center. He serves on the board of directors of Tessera Technologies, Inc., an independent licensor of intellectual property and a designer and manufacturer of digital optics and imaging technology to the mobility industry, and on the board of directors of Leapfrog Enterprises, Inc., a leading designer, developer and marketer of innovative technology-based learning platforms and related proprietary content for children. Dr. Nagel also serves on the board of directors of Vonage Holdings Corp., a leading provider of high-quality voice and messaging services over broadband networks and Previously, Mr. Nagel served on the Board of Unwired Planet, Inc. (formerly Openwave Systems Inc.), an independent provider of software solutions for the communications and media industries. Dr. Nagel holds B.S. and M.S. degrees in engineering and a Ph.D. in perception and mathematical psychology, all from UCLA.
For the following reasons, the Board concluded that Dr. Nagel should serve as a director of Align. Dr. Nagel has considerable business experience in the technology industry serving as president and chief executive officer of PalmSource and chief technology officer at AT&T. Dr. Nagel's drive for innovation, evidenced during his tenure at PalmSource, AT&T and Apple, enhances the knowledge of our Board and provides useful insights to management in connection with our focus on technology innovation. Dr. Nagel's experience as a member of the board of directors of various public companies, including as member or chairman of their Compensation Committees, gives him insight and perspective into current best practices at the Board and Compensation Committee level and enables him to be an effective contributing member.
|
|
|
|
|
|
Thomas M. Prescott
Age: 56
Director since 2002
No Board committees
|
|
Mr. Prescott has served as our President and Chief Executive Officer and a member of the Board since March 2002. Prior to joining Align, Mr. Prescott was president and chief executive officer of Cardiac Pathways, Inc. from May 1999 to August 2001 and a consultant for Boston Scientific Corporation from August 2001 to January 2002 after its acquisition of Cardiac Pathways in August 2001. Prior to Cardiac Pathways, Mr. Prescott held various sales, general management and executive roles at Nellcor Puritan Bennett, Inc. from April 1994 to May 1999, and various management positions at GE Medical Systems from October 1987 to April 1994. In addition, Mr. Prescott served in sales, marketing and management roles at Siemens from December 1980 to July 1986. He received his B.S. in Civil Engineering from Arizona State University and Masters in Management from Northwestern University.
For the following reasons, the Board concluded that Mr. Prescott should serve as a director of Align. As CEO, Mr. Prescott is the only officer to sit on our Board. With over 10 years of experience at our company, he has deep knowledge and understanding of Align and its business. Mr. Prescott’s prior experience as CEO of another publicly traded medical device company demonstrates his leadership capability and business acumen. His experience with strategic and operational issues in the life sciences industry along with his service on the board of directors of other companies in this industry gives him insight into the issues facing this industry and brings valuable expertise to our Board.
|
|
Greg J. Santora
Age: 61
Director since 2003
Board committees:
Audit (Chair)
|
|
Mr. Santora has served as a director of Align since July 2003. Mr. Santora served as Chief Financial Officer at Shopping.com, a provider of internet-based comparison shopping resources, from December 2003 until September 2005. From 1997 through 2002, he served as Senior Vice President and Chief Financial Officer for Intuit, Inc., a provider of small business and personal finance software. Prior to Intuit, Mr. Santora spent nearly 13 years at Apple Computer in various senior financial positions including senior finance director of Apple Americas and senior director of internal consulting and audit. Mr. Santora, who began his accounting career with Arthur Andersen L.L.P., has been a CPA since 1974. He served on the board of directors of Taleo Corporation, a provider of on-demand talent management solutions until its acquisition by Oracle Corporation in April 2012. He previously served on the board of directors of Digital Insight Corporation. Mr. Santora holds a B.S. in Accounting from the University of Illinois and an M.B.A. from San Jose State University.
For the following reasons, the Board concluded that Mr. Santora should serve as a director of Align. Mr. Santora is an experienced financial leader with over 35 years of finance and accounting experience gained through his education and work at a major accounting firm and his later positions as chief financial officer of Intuit and Shopping.com. The compliance, financial reporting and audit expertise Mr. Santora gained in his senior finance and operations roles, including as chief financial officer, has proven valuable in addressing issues that have arisen at Align during Mr. Santora’s tenure as Audit Committee chairman. Mr. Santora very recently served on the board of directors and audit committee of another publicly traded company, which gives him insight and perspective into current best practices with respect to finance organizations and the audit committee function.
|
|
Warren S. Thaler
Age: 49
Director since 2004
Board committees:
Audit, Nominating and Governance, and Technology
|
|
Mr. Thaler has served as a director of Align since June 2004. Since 2001, Mr. Thaler has been President of Gund Investment Corporation, an investment firm owned by Gordon Gund with holdings in real estate as well as public and private equity securities. Since 1990, Mr. Thaler has served on the board of directors of several privately held companies owned by the Gund family. From 1990 to 2005, Mr. Thaler was on the board of directors of the Cleveland Cavaliers and Gund Arena Company and from 2001 to 2005 represented the Cleveland Cavaliers as its Alternate Governor at meetings of the National Basketball Association’s Board of Governors. Mr. Thaler received his B.A. from Princeton University and his M.B.A. from Harvard University.
For the following reasons, the Board concluded that Mr. Thaler should serve as a director of Align. Mr. Thaler’s demonstrated executive level management skills make him an important advisor to our Board. His success in building businesses as well as his finance and investment experience gained at Gund and through his education makes Mr. Thaler well suited for our Audit Committee. Mr. Thaler’s business background makes him a valuable component of a well rounded Board and a key member of the Board’s audit, nominating and governance, and technology committees.
|
|
•
|
Director Stock Ownership Guidelines.
The guidelines provide that each director should own shares of Align’s common stock equal in market value to three times the cash portion of the Board’s annual retainer. The guideline for the Chairman of the Board is equal to the amount calculated for each of the other non-executive members of the Board. By way of example, assuming the cash portion of the Board’s annual retainer is $40,000, the target ownership level for a director, including the Chairman, would be $120,000. Directors are expected to attain the minimum level of target ownership within a period of five years from the effective date of the policy. Any new director will be expected to attain the minimum level of target ownership within a period of five years from the date he or she is first elected to the Board. In addition, in March 2013, the Compensation Committee of the Board of Directors determined to increase the director ownership ratio from three times the cash portion of the Board's annual retainer to five times. Currently, all directors are in compliance with the revised policy.
|
|
•
|
Executive Officer Stock Ownership Guidelines.
The target ownership guideline set for each executive is based on that person’s relative level of seniority and responsibility. For our CEO, the ratio is 3.0 times his annual base salary. For our CFO, the ratio is 0.75 times his annual base salary. For each other executive officer, the ratio is 0.5 times such officer’s annual base salary. Once established, an executive officer’s target ownership guideline does not re-adjust automatically as a result of changes in his or her base salary or changes in the price of the company’s stock. Executive officers are required to achieve the guideline within five years of becoming an executive officer, or, in the case of persons who were executive officers at the time the guidelines were adopted, within five years of the date of adoption of the guidelines. In addition, in March 2013, the Compensation Committee of the Board of Directors determined to increase Mr. Prescott's ratio from 3 times his annual base salary to 5 times his annual base salary. The Committee also increased the ratio for each executive officer other than the CEO to 1.0 times each such executive officer's base salary. Currently, each executive officer is in compliance with the revised stock ownership guidelines, as amended.
|
|
•
|
shares of Align common stock held directly by the director or officer or in trust for the benefit of the director or officer or his or her family member living in the same household,
|
|
•
|
50% of the gain on vested in-the-money stock options, and
|
|
•
|
shares of underlying Align restricted stock units held directly by a director or officer, whether or not yet vested.
|
|
Board Member
|
Board
|
|
Audit
Committee
|
|
Compensation
Committee
|
|
Nominating
and
Governance
Committee
|
|
Technology
Committee
|
|
David E. Collins
|
ü
|
|
ü
|
|
ü
|
|
|
|
|
|
Joseph Lacob
|
ü
|
|
|
|
|
|
Chair
|
|
ü
|
|
C. Raymond Larkin Jr.
|
Chair
|
|
|
|
|
|
ü
|
|
|
|
George J. Morrow
|
ü
|
|
|
|
Chair
|
|
|
|
|
|
Dr. David C. Nagel
|
ü
|
|
|
|
ü
|
|
|
|
Chair
|
|
Greg J. Santora
|
ü
|
|
Chair
|
|
|
|
|
|
|
|
Warren S. Thaler
|
ü
|
|
ü
|
|
|
|
ü
|
|
ü
|
|
Number of Meetings held in 2012
|
10
|
|
14
|
|
9
|
|
2
|
|
2
|
|
•
|
the highest personal and professional ethics and integrity;
|
|
•
|
proven achievement and competence in the nominee’s field and the ability to exercise sound business judgment;
|
|
•
|
skills and experience that are complementary to those of the existing Board;
|
|
•
|
the ability to assist and support management and make significant contributions to Align’s success; and
|
|
•
|
an understanding of the fiduciary responsibilities that is required of a member of the Board and the commitment of time and energy necessary to diligently carry out those responsibilities.
|
|
•
|
our compensation program is designed to provide a balanced mix of cash and equity, annual, and longer-term incentives in order to encourage strategies and actions that are in Align’s long-term best interests;
|
|
•
|
base salaries are consistent with an employee’s responsibilities so that they are not motivated to take excessive risks to achieve a reasonable level of financial security;
|
|
•
|
we establish performance goals under our annual cash incentive plan that we believe (A) are reasonable in light of past performance and market conditions, (B) encourage success without encouraging excessive risk taking to achieve short-term results, and therefore do not encourage unnecessary or excessive risk-taking;
|
|
•
|
the performance goals that determine payouts under our annual cash incentive plans are company-wide in order to encourage decision-making that is in the best long-term interests of Align and our stockholders as a whole;
|
|
•
|
the performance goals under our annual cash incentive plan include the achievement of non-financial, key strategic objectives that put an emphasis on the achievement of results intended to build value over the longer-term;
|
|
•
|
under our annual cash incentive plans, achievement of performance goals at levels below full target reduces only the payout related to that goal, not the other goals, and therefore does not result in an “all-or-nothing” approach;
|
|
•
|
each performance goal under our annual cash incentive plan has a maximum cap on achievement;
|
|
•
|
the Compensation Committee has discretion over annual cash incentive program payouts;
|
|
•
|
for our executive officers, we use a portfolio of equity based incentives that incent performance over a variety of time periods with respect to several balanced goals:
|
|
•
|
RSUs retain value even in a depressed market making it less likely that employees take unreasonable risks to get, or keep, equity grant “in the money”; and
|
|
•
|
performance-based market stock units, or MSUs, measure relative stockholder return over a three-year performance cycle; and
|
|
•
|
executive officers are subject to share ownership guidelines.
|
|
Description
|
Current Fee
|
||
|
Annual retainer for Chairman of the Board (1)
|
$
|
210,000
|
|
|
Monthly retainer for membership on the Board (excluding the Chairman of the Board)
|
$
|
3,000
|
|
|
Additional monthly retainer for Chair of Audit and Compensation Committees
|
$
|
1,500
|
|
|
Additional monthly retainer for Chair of Technology Committee
|
$
|
833
|
|
|
Additional monthly retainer for Chair of Nominating and Governance Committee
|
$
|
500
|
|
|
Each face to face meeting of the Board
|
$
|
1,500
|
|
|
Each telephonic meeting of the Board
|
$
|
750
|
|
|
Each face to face Committee meeting
|
$
|
1,000
|
|
|
Each telephonic Committee meeting
|
$
|
500
|
|
|
(1)
|
The Chairman of the Board does not receive any compensation for Board or committee attendance other than the annual retainer.
|
|
Name
|
Fees
earned
or paid
in cash
($)
|
|
Stock
awards
($)(1)
|
|
|
Total ($)
|
|||
|
David E. Collins
|
61,500
|
|
|
240,471
|
|
|
|
301,971
|
|
|
Joseph Lacob
|
52,500
|
|
|
240,471
|
|
|
|
292,971
|
|
|
C. Raymond Larkin Jr. (2)
|
210,000
|
|
|
359,145
|
|
|
|
569,145
|
|
|
George Morrow
|
71,000
|
|
|
240,471
|
|
|
|
311,471
|
|
|
Dr. David Nagel
|
64,246
|
|
|
240,471
|
|
|
|
304,717
|
|
|
Greg Santora
|
75,500
|
|
|
240,471
|
|
|
|
315,971
|
|
|
Warren Thaler
|
60,000
|
|
|
240,471
|
|
|
|
300,471
|
|
|
(1)
|
The amounts shown in this column reflect the aggregate grant date fair value computed in accordance with FASB ASC Topic 718 of awards of restricted stock units. There can be no assurance that the grant date fair value amounts will ever be realized. The restricted stock unit awards are time based awards, and are not subject to performance or market conditions.
|
|
(2)
|
Mr. Larkin is the Chairman of the Board. The Chairman of the Board does not receive any compensation for Board or committee attendance other than the annual retainer.
|
|
Name
|
|
Stock
Awards
|
|
|
Mr. Collins
|
|
7,700
|
|
|
Mr. Lacob
|
|
7,700
|
|
|
Mr. Larkin
|
|
11,500
|
|
|
Mr. Morrow
|
|
7,700
|
|
|
Dr. Nagel
|
|
7,700
|
|
|
Mr. Santora
|
|
7,700
|
|
|
Mr. Thaler
|
|
7,700
|
|
|
|
2012
|
|
2011
|
||||
|
Audit fees (1)
|
$
|
1,909,999
|
|
|
$
|
1,899,650
|
|
|
Audit-related fees (2)
|
61,648
|
|
|
607,965
|
|
||
|
Tax fees (3)
|
764,965
|
|
|
546,027
|
|
||
|
Total fees:
|
$
|
2,736,612
|
|
|
$
|
3,053,642
|
|
|
(1)
|
Audit fees
—These are fees for professional services performed by PwC for the annual audit of Align’s financial statements and review of financial statements included in Align’s quarterly filings, and services that are normally provided in connection with statutory and regulatory filings or engagements, and attest services, except those not required by statute or regulation.
|
|
(2)
|
Audit-related fees
—These are fees for technical advisory consultations performed by PwC that are reasonably related to the performance of the audit or review of Align’s financial statements and are not reported under “Audit fees”, including fees for due diligence services.
|
|
(3)
|
Tax fees
—These are fees for professional services performed by PwC with respect to tax compliance, tax advice and tax planning.
|
|
•
|
the integrity of Align’s financial statements;
|
|
•
|
Align’s compliance with legal and regulatory requirements;
|
|
•
|
the independent registered public accountant’s qualifications, independence and performance;
|
|
•
|
adequacy of Align’s internal accounting and financial controls; and
|
|
•
|
Align’s internal audit department.
|
|
•
|
providing guidance with respect to Align’s relationship with the independent auditors, including having responsibility for their appointment, compensation and retention;
|
|
•
|
reviewing the results and audit scope;
|
|
•
|
approving audit and non-audit services;
|
|
•
|
reviewing and discussing with management the quarterly and annual financial reports;
|
|
•
|
overseeing and reviewing Align’s risk management policies; and
|
|
•
|
overseeing management’s implementation and maintenance of effective systems of internal controls.
|
|
Respectfully submitted by:
|
|
|
|
AUDIT COMMITTEE
|
|
Greg J. Santora, Chair
|
|
David E. Collins
|
|
Warren S. Thaler
|
|
•
|
Approximately 80%—90% of total compensation is variable and tied to achievement of internal performance targets or Align's stock price performance;
|
|
•
|
Since Align’s achievement of internal performance targets was at or near target in 2012 compared to significantly above target in 2011, each executive officer received less cash incentive award compensation compared to 2011;
|
|
•
|
Align granted long-term equity awards that link the interests of our executives with those of our shareholders. Specifically, those awards include performance-based market stock units, which are earned based on a comparison of Align’s stock price performance to the Nasdaq Composite index over a 3-year performance period;
|
|
•
|
Executive officers are not entitled to any tax gross-up treatment on any severance or change-of-control benefits;
|
|
•
|
Align’s compensation programs are reviewed regularly by the Compensation Committee, which has determined the Company’s compensation programs do not create inappropriate or excessive risk that is likely to have a material adverse effect on the Company;
|
|
•
|
Align continued to demonstrate its prudent use of equity balancing stockholder concerns with the motivation of our executive officers to achieve the Company’s business goals and create long-term stockholder value. In 2012, Align’s overall equity award adjusted burn rate (which counts each RSU and earned MSU award as 2.0 shares) was 2.23%.
|
|
•
|
An increase by 7,000,000 shares in the number of shares authorized for issuance under the Incentive Plan, from 13,283,379 to 20,283,379 shares (plus up to an aggregate of 5,000,000 shares that are or would have been returned to our 2001 Stock Incentive Plan (the “2001 Plan”) as result of termination of options or repurchase of shares on or after March 28, 2005).
|
|
•
|
Each share subject to awards of restricted stock, restricted stock units, performance shares and performance units with a per share or unit purchase price less than the fair market value of a share of our common stock on the award's grant date (“full value awards”) that are granted on or after May 16, 2013, will be counted against the Incentive Plan's share reserve (the “fungible ratio”) as 1.9 shares for every one share subject to such award. Shares subject to such awards that are returned to the Incentive Plan will be credited as 1.9 shares. The fungible ratio of awards granted prior to May 16, 2013, was 1.5 shares for every one share subject to such award and each share subject to such awards that are returned to the Incentive Plan will continue to be credited as 1.5 shares.
|
|
•
|
In any fiscal year of Align, non-employee directors may be granted awards covering a maximum of 100,000 shares (other than any awards granted to such director while he or she was a consultant or employee of Align or its affiliates).
|
|
•
|
Full value awards granted under the Incentive Plan will be subject to vesting criteria as determined by the administrator of the Incentive Plan, which the administrator may reduce or waive following the grant of a full value award. Prior to the Amendment, full value awards were required to vest at a rate not earlier than as to one-third of the shares annually from the award's grant date, unless the award was subject to performance-based vesting over a performance period of at least one year, and any vesting criteria could be reduced or waived only upon or in connection with a change in control of Align or the award holder's termination of service with Align.
|
|
•
|
Aligns director, employee and stockholder interests.
We believe that an effective and competitive employee incentive program is imperative for the success of our business. We rely on our experienced employees and their efforts to help Align achieve its business objectives. At Align, equity awards constitute a key component of our incentive and retention programs because the Board and the Compensation Committee of our Board believe that equity compensation encourages our employees to act like owners of the business, motivating them to work toward our success and rewarding their contributions by allowing them to benefit from increases in the value of our shares.
|
|
•
|
Attracts and retains talent.
Talented, motivated and effective executives and employees are essential to executing our business strategies. Stock-based compensation has been an important component of total compensation at Align for many years because such compensation enables us to effectively recruit executives and other employees while encouraging them to act and think like owners of our company. If the Amendment to the Incentive Plan is approved, we believe we will maintain our ability to offer competitive compensation packages to both retain our best performers and attract new talent.
|
|
•
|
Supports our pay-for-performance philosophy
. The Compensation Committee of our Board believes that stock-based compensation is inherently performance-based, as the benefit the recipient receives increases as our stock price rises. The same attribute also directly links equity award compensation with stockholder value creation.
|
|
•
|
Historical Grant Practices
. Our Board considered the historical amounts of equity awards that Align has granted in the past 3-years. The following table sets forth information regarding awards granted and earned and the run rate (burn rate) for each of the last 3 fiscal years. Our 3-year adjusted burn rate of 2.64% (adjusted so that each full-value award is counted as two stock options) is significantly below industry guidelines recommended by Institutional Shareholder Services of 5.09%.
|
|
|
|
2012
|
|
2011
|
|
2010
|
|||
|
Stock options granted
|
|
—
|
|
|
421,000
|
|
|
1,501,164
|
|
|
Restricted stock units granted
|
|
897,300
|
|
|
799,000
|
|
|
427,195
|
|
|
Weighted average basic common shares outstanding during the fiscal year
|
|
80,528,315
|
|
|
77,987,999
|
|
|
75,825,000
|
|
|
% of Basic Total Shares Outstanding
(full value awards counted using a ratio of 2:1)
|
|
2.23
|
%
|
|
2.59
|
%
|
|
3.11
|
%
|
|
•
|
Forecasted Grant Practices
. We currently forecast granting options and full value awards (in the form of restricted stock units and market stock units) covering approximately 8.5 million shares over the next 3 year period, which is equal to 10% of our common shares outstanding as of March 1, 2013. In particular, and as part of its analysis, the compensation committee considered our proposed share reserve in light of the “fungible ratio,” a ratio established to account for the economic and dilutive differences between “full value” equity awards such as restricted stock units and market stock units, which will generally result in some value being paid to an employee upon vesting regardless of stock price performance, and stock options, which require that our stock price trade higher than the applicable exercise price in order for a participant to realize value. Because of these differences, we are generally required to deliver more shares subject to options in order to provide the same estimated grant value relative to restricted stock or restricted stock units. For purposes of our plan, the compensation committee established a “fungible ratio” of 1.9:1, meaning that shares subject to restricted stock units and market stock units, and similar full value awards will count against our available reserves at the rate of 1.9 shares for each share subject to the award. In determining the fungible ratio, the compensation committee considered information from third-party databases. Stock options would reduce the available reserve on a share for share basis based on the number of shares subject to the option.
|
|
•
|
Awards Outstanding Under Existing Grants
. Align has outstanding, as of March 1, 2013, stock options covering 2,587,091 shares, 1,914,592 unvested restricted stock units and 561,900 unvested market stock units (calculated assuming they vest at their maximum value of 150% of target). Accordingly, the approximately 5,063,583 shares subject to outstanding awards (commonly referred to as the “overhang”) represent approximately 6% of our outstanding shares. Subject to approval by our stockholders, the overhang resulting from the number of shares requested under the plan will be approximately 18%.
|
|
•
|
81,714,769 shares of our common stock were outstanding.
|
|
•
|
The market value of one share of our common stock was $31.13.
|
|
•
|
The number of shares remaining available for future grants, under the Incentive Plan was 2,576,123.
|
|
•
|
The weighted average exercise price of all outstanding stock options was $15.40.
|
|
•
|
The weighted average remaining contractual term for all outstanding stock options was 4.07 years.
|
|
Name of Individual or Group
|
|
Number of Shares Subject to RSUs (#)
|
|
Weighted Average per Unit Grant date Dollar Value of RSUs
($)
|
|
Number of Shares Subject to MSUs (#)
|
|
Weighted Average per Unit Grant date Dollar Value of MSUs
($)
|
||||
|
Thomas M. Prescott
|
|
62,500
|
|
|
27.22
|
|
|
62,500
|
|
|
29.45
|
|
|
Kenneth B. Arola
|
|
16,200
|
|
|
27.22
|
|
|
16,200
|
|
|
29.45
|
|
|
Len M. Hedge
|
|
24,000
|
|
|
27.22
|
|
|
24,000
|
|
|
29.45
|
|
|
Jennifer M. Erfurth
|
|
40,000
|
|
|
26.42
|
|
|
—
|
|
|
—
|
|
|
Richard Twomey
|
|
16,500
|
|
|
27.22
|
|
|
16,500
|
|
|
29.45
|
|
|
Dana C. Cambra
|
|
17,250
|
|
|
27.22
|
|
|
17,250
|
|
|
29.45
|
|
|
All executive officers, as a group
|
|
229,450
|
|
|
27.08
|
|
|
189,450
|
|
|
29.45
|
|
|
All directors who are not executive officers, as a group
|
|
57,700
|
|
|
31.23
|
|
|
—
|
|
|
—
|
|
|
All employees who are not executive officers, as a group
|
|
610,150
|
|
|
27.71
|
|
|
—
|
|
|
—
|
|
|
Plan Category
|
|
Number of securities to be issued upon exercise of outstanding options, RSUs and MSUs (a)
|
|
Weighted average exercise price of outstanding options (b)
|
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c)
|
|
Equity compensation plans approved by security holders
|
|
5,041,331(1)(2)
|
|
$15.21
|
|
4,101,652(3)
|
|
(1)
|
This number reflects the number of securities to be issued upon exercise of outstanding options and restricted stock units under the 1997 Equity Incentive Plan, the 2001 Stock Incentive Plan, and the 2005 Incentive Plan. The 1,500,193 restricted stock units included in this number have an exercise price of zero.
|
|
(2)
|
We are unable to ascertain with specificity the number of securities to be issued upon exercise of outstanding rights under the Employee Stock Purchase Plan or the weighted average exercise price of outstanding rights under the Employee Stock Purchase Plan.
|
|
(3)
|
This number of securities reflects securities available for future issuance under the 2005 Stock Incentive Plan and the 2012 Stock Incentive Plan. Our 2005 Incentive Plan, as amended, provides for the granting of incentive stock options, non-statutory stock options, restricted stock units, stock appreciation rights, performance units and performance shares to employees, non-employee directors, and consultants. Shares granted as an award of restricted stock, restricted stock unit, performance share or performance unit are counted against the authorized share reserve as one and one-half (1
1/2
) shares for every one (1) share subject to the award, and any shares canceled will be returned at the same ratio. An aggregate of 5,000,000 shares that would have been returned to our expired 2001 Stock Incentive Plan as a result of options canceled or shares repurchased, can be added to the shares available under the 2005 Incentive Plan. As of December 31, 2012, we have a total of 16,283,379 shares authorized and reserved, of which 4,103,752 shares are available for issuance. This includes 2,377,616 shares that have been transferred from the 2001 Stock Incentive Plan. We issue new shares from our pool of authorized but unissued shares to satisfy the exercise and vesting obligations of our stock-based compensation plans. Our 2001 Employee Stock Purchase Plan (the “2001 Purchase Plan”) consists of consecutive overlapping twenty-four month offering periods with four six-month purchase periods in each offering period. Employees purchase shares at 85% of the fair market value of the common stock at either the beginning of the offering period or the end of the purchase period, whichever is lower. The 2001 Purchase Plan expired on January 31, 2011. In May 2010, our shareholders approved the 2010 Employee Stock Purchase Plan (the “2010 Purchase Plan”) to replace the 2001 Purchase Plan. The terms and features of the 2010 Purchase Plan are substantially the same as the 2001 Purchase Plan and will continue until terminated by either the Board or its administrator. The maximum number of shares available for issuance under the 2010 Purchase Plan is 2,400,000 shares. During the year ended December 31, 2012, 2011 and 2010, we issued 336,382, 482,542, and 643,129 shares, respectively, at average prices of $17.98, $10.63, and $7.21, respectively. As of December 31, 2012, 1,899,845 shares remain available for future issuance.
|
|
•
|
net revenue growth of 16.7% with record revenues of $560.0 million;
|
|
•
|
non-GAAP operating income growth of 22.9%; and
|
|
•
|
non-GAAP EPS growth of 20.6%.
|
|
•
|
Entered into a new market segment with the launch of Invisalign Express 5, a five stage aligner product for North America and Invisalign i7, a seven stage aligner product for Europe, both of which help doctors treat more patients who could benefit from minor tooth movements, but are reluctant to invest in comprehensive treatment due to cost.
|
|
•
|
Announced the Invisalign Outcome Simulator application, our first Invisalign chair-side application for the iTero and iOC scanners, providing our customers with a powerful tool to help their patients visualize the benefits possible with Invisalign treatment.
|
|
•
|
Announced a new SmartTrack aligner material, a highly elastic, a proprietary material, that delivers gentle, more constant force considered ideal for orthodontic tooth movements which became the new standard aligner material for Invisalign clear aligner products starting in 2013.
|
|
•
|
Grew our Invisalign teenage segment 20.8% year over year demonstrating our continued progress and share gain among teens, defined as 11 to 19 years old worldwide.
|
|
•
|
Grew international Invisalign case shipments 23% driven by increased adoption in Europe and Asia Pacific, expansion into new emerging markets such as China, Russia, and the Middle East, as well as new direct to consumer marketing programs in Europe.
|
|
•
|
Stockholders indicated strong support for our executive compensation program in 2012.
In 2012, we held our second annual advisory vote on our executive compensation as described in last year's proxy statement. Last year's proxy statement detailed our fiscal 2011 executive compensation. Approximately 91% of the total votes cast at our annual meeting voted in favor of our 2012 say-on-pay resolution. As we evaluated our executive compensation practices since that vote, we were mindful of the strong support our stockholders expressed for our executive compensation program. As a result, the Compensation Committee generally believes that the say-on-pay vote affirmed stockholder support of our approach to executive compensation and they did not believe it was necessary to make any significant changes to our executive compensation program.
|
|
•
|
Our compensation program continues to emphasize performance-based pay.
Our compensation program is designed to pay more when our financial and strategic performance is robust and less when it is not, providing built-in flexibility in the management of our operating expenses and enabling us to preserve strategic programs when economic conditions are unfavorable. A significant portion of our executive officers’ compensation is variable and tied to the success of our business and the individual performance of our executives. Consistent with this pay-for-performance orientation, Align believes that annual cash incentive (bonus) awards and long-term equity compensation should together represent the most significant portion of total direct compensation. As a result, a larger portion of our executive officers’ total compensation is at risk relative to Align’s other employees. We believe this is appropriate because our executive officers bear the greatest responsibility for Align’s results and can exert the greatest influence on Align’s performance. As illustrated by the charts below, in fiscal 2012, approximately 87% of our CEO’s total compensation and approximately 80% of our other named executive officers (except for Mr. Cambra and Ms. Erfuth) total compensation was subject to annual performance goals or tied to the value of our common stock.
|
|
•
|
Equity awards are tied to the value of our common stock.
Value received under our annual equity awards varies based on our stock price performance. Payouts of our market stock unit (MSU) awards to our executive officers vary based on the relative performance of our stock compared to the Nasdaq Composite Index over a three-year performance period. Any value received by our executive officers from annual restricted stock unit awards is contingent upon our stock price performance.
Our Compensation Committee specifically designed our MSU award program to closely tie actual long-term performance with long-term pay, and total stockholder return has been, and is expected to continue to be, the key measurement of our performance under this program.
|
|
•
|
Annual cash incentive awards subject to annual performance goals.
The Committee seeks to motivate management to continuously improve the financial performance of the Company and to achieve our key strategic priorities through a cash incentive (bonus) plan that rewards higher performance with increased incentive
|
|
•
|
Changes to Equity Awards Portfolio.
The Compensation Committee has historically granted time-vested stock options to tie compensation to absolute increases in our stock price over multi-year periods. Stock options are rights to purchase our Common Stock on or after the vesting date at the closing price of our Common Stock on the date of grant. Unlike RSUs, our stock price must increase over the exercise price set at the date of grant for stock options to have any value. Effective for 2012, the Compensation Committee determined to no longer grant stock options to our executive officers and moved to a portfolio consisting of approximately 1/2 performance-based market stock units, or MSU value, to further align the compensation of our NEOs with Company performance and stockholders' interest and 1/2 time-based RSUs to promote retention of our leadership team. The Compensation Committee believes that this equity mix will more consistently meet our two principle goals of rewarding results that increase stockholder value while ensuring the retention of our most valuable asset, our employees.
|
|
•
|
Relationship Between Company Performance, Stock Price and CEO Compensation.
The following illustrates the directional relationship between Align’s performance, based on two of our key financial metrics and our stock price, and the compensation of our CEO from 2010 to 2012. These two key financial metrics are used in our cash incentive compensation plan and reflect our continued focus on growth and profitability over the long term.
|
|
1)
|
Non-GAAP Revenue was adjusted in 2010 to exclude the release of $14.3 million of previously deferred revenue for Invisalign Teen. GAAP revenue in 2010 was $387.1 million. Non-GAAP Revenue was adjusted in 2012 to exclude the release of $4.9 million of previously deferred revenue for Invisalign case refinement.
|
|
2)
|
Non-GAAP Operating Income was adjusted as approved by the Compensation Committee in each of 2010, 2011 and 2012 to exclude certain items that are not indicative of our core operating performance. See Appendix A of this proxy statement for a reconciliation of adjusted Non-GAAP profit from operations and Non-GAAP net profit to the most comparable GAAP measurements.
|
|
•
|
The Compensation Committee is composed solely of independent directors and it directly retains an independent compensation consultant.
|
|
•
|
We elected to hold an annual advisory say-on-pay vote, and the Compensation Committee considers the outcome of the advisory vote in making compensation decisions.
|
|
•
|
In 2008, Align adopted Stock Ownership Guidelines for our executives in order to further link the decisions they are responsible for in the near-term to the long-term success of the Company. In March 2013, the Compensation Committee determined to increase Mr. Prescott's ratio from 3.0 times his annual salary to 5.0 times his annual salary. Our CEO currently holds 171,520 shares of our common stock outright with a value as of fiscal year end of more than eight times his 2012 base salary. In
|
|
•
|
Align’s executive compensation policies are structured to discourage inappropriate risk-taking by our executives. The Compensation Risk Assessment located on page 13 of this proxy statement describes the Compensation Committee’s assessment that the risks arising from our company-wide compensation programs are reasonable, in the best interest of our stockholders, and not likely to have a material adverse effect on us.
|
|
•
|
Our insider trading policy prohibits our executive officers from “hedging” ownership in Align by engaging in any short sales or trading in any options contracts involving our securities.
|
|
•
|
Offer competitive compensation
. We seek to provide competitive compensation opportunities to attract, retain and incent superior talent.
|
|
•
|
Reward performance
. A significant portion of total compensation for our NEOs is tied to the achievement of financial and strategic objectives. We believe that this supports our pay-for-performance philosophy by directly and substantially linking rewards to the achievement of measurable financial targets and a shared set of critical strategic priorities. By also rewarding individual performance, we seek to foster a meritocracy.
|
|
•
|
Link the interests of our executives with those of our stockholders
. A significant portion of total compensation for our NEOs is tied to the achievement of financial and strategic objectives and is in the form of long-term equity-based compensation. This structure is designed to focus decision-making and behavior on goals that are consistent with Align’s overall strategy.
|
|
Responsible Party
|
|
Roles and Responsibilities
|
|
Compensation Committee
(Comprised solely of independent directors and reports to the Board of Directors)
|
|
• Sets Align’s overall compensation philosophy, which is reviewed and approved by the Board of Directors.
• Reviews and approves our compensation programs; designs and monitors the execution of these programs.
• Reviews and approves all equity compensation awards for our employees, including our executive officers.
• Reviews and approves all cash based compensation arrangements for our executive officers (other than our CEO).
• Reviews and recommends to our Board of Directors all cash based compensation arrangements for our CEO.
|
|
Responsible Party
|
|
Roles and Responsibilities
|
|
Consultant to the Compensation Committee
(Compensia, Inc.–an independent executive compensation consulting firm retained directly by the
Compensation Committee to assist it in performing its responsibilities)
|
|
Compensia attends meetings of the Committee from time to time and communicates outside of meetings with members of the Committee and management with respect to the design and assessment of compensation packages for our executive officers. Specifically, Compensia assists the Committee’s executive compensation-setting process by:
• Analyzing whether the compensation packages of our executive officers were consistent with our compensation philosophy and competitive within the market relative to our peer companies.
• Defining the appropriate peer group of comparable companies.
• Assisting in the design of our compensation programs for executives and board members, including discussing evolving compensation trends.
• Reviewing the effectiveness of our compensation programs.
• Compiling and providing market data to assist in setting our compensation philosophy, plan parameters and measures.
Other than its role as consultant to the Committee, Compensia performed no work for the Company.
|
|
Executive Officers
(Assisted by other Company staff members)
|
|
Management's role is to advise the Committee regarding the alignment and weighting of our performance measures under our annual cash incentive awards with our overall strategy, the impact of the design of our equity incentive awards on our ability to attract, motivate and retain highly talented executives and the competitiveness of our compensation program. Our CEO conducts performance reviews for the other NEOs, and makes recommendations to the Compensation Committee with respect to the other NEOs’ compensation. Any executive officer who participates in Compensation Committee meetings leaves the meetings during discussions and deliberations of individual compensation actions affecting them personally and during the Compensation Committee’s executive sessions. Ultimately all decisions regarding executive compensation are made by the Compensation Committee or in the case of CEO cash compensation, the full Board upon the recommendation of the Compensation Committee.
|
|
•
|
market comparison data (peer group data and survey data);
|
|
•
|
subjective elements, such as:
|
|
•
|
the scope of the executive’s role;
|
|
•
|
the executive’s:
|
|
•
|
experience;
|
|
•
|
qualifications;
|
|
•
|
skills; and
|
|
•
|
performance during the fiscal year (see discussion below on “
Role of Individual Performance”
);
|
|
•
|
internal equity; and
|
|
•
|
Align’s operational and financial performance.
|
|
•
|
Industry
—medical device companies and software as a service companies (SaaS). We believe that the SaaS industry is a relevant industry for market comparison purposes due to the integral role that software systems and software development has in our products and services;
|
|
•
|
Market Capitalization
—companies with a market capitalization of between approximately $600 million and $5.5 billion, based upon the companies’ trading ranges at the time of selection; and
|
|
•
|
Revenue
—companies with revenue of between approximately $130 million to $1.2 billion, based upon the last four quarters of revenue at the time of selection.
|
|
Software-as-a Service
|
Medical Device
|
|
Ariba
|
Accuray
|
|
athenahealth
|
Conceptus
|
|
Blackbaud
|
Conmed Corp.*
|
|
Blackboard
|
Gen-Probe Incorporated
|
|
Concur Technologies
|
Haemonetics
|
|
Informatica
|
Immucor
|
|
JDA Software Group
|
Integra Lifesciences
|
|
MicroStrategy
|
Masimo
|
|
NetSuite
|
Merit Medical Systems
|
|
Qlik*
|
Natus Medical
|
|
Rackspace Hosting*
|
NuVasive
|
|
SuccessFactors
|
Resmed*
|
|
Taleo Corp.
|
Sirona Dental Systems
|
|
Ultimate Software Group
|
SonoSite
|
|
Websense
|
Thoratec
|
|
|
Volcano
|
|
|
Zoll Medical
|
|
•
|
Radford Global Technology Survey—the scope of the data included from this survey was companies located throughout the United States with revenues of $200 million to $500 million;
|
|
•
|
Radford Life Sciences Survey—the scope of the data included from this survey was companies located throughout the United States with more than 150 employees.
|
|
Element of Compensation
|
Target Percentile
|
|
Base salary
|
50
th
percentile
|
|
Target total cash compensation
|
65
th
to 75
th
percentile
|
|
Equity compensation
|
50
th
to 75
th
percentile
|
|
•
|
base salary;
|
|
•
|
annual cash incentive awards;
|
|
•
|
long-term equity-based incentive grants; and
|
|
•
|
severance and change of control arrangements.
|
|
Name
|
2011
|
|
2012
|
|
2011/2012
% Increase
|
|||||
|
Thomas M. Prescott
|
$
|
575,000
|
|
|
$
|
615,000
|
|
|
7
|
%
|
|
Kenneth B. Arola
|
$
|
326,970
|
|
|
$
|
340,269
|
|
|
4
|
%
|
|
Len M. Hedge
|
$
|
360,180
|
|
|
$
|
375,374
|
|
|
4
|
%
|
|
Jennifer M. Erfurth (1)
|
N/A(1)
|
|
|
$
|
320,000
|
|
|
N/A
|
|
|
|
Richard Twomey
|
$
|
317,189
|
|
|
$
|
332,951
|
|
|
5
|
%
|
|
Dana C. Cambra
|
$
|
331,484
|
|
|
$
|
349,813
|
|
|
5.5
|
%
|
|
(1)
|
Ms. Erfurth joined Align in October 2012. Although her base salary was set at $320,000, she earned $67,692 during the three month period she was employed by Align in 2012.
|
|
Name
|
Target Award
Opportunity (% of
Base Salary)
|
|
|
Thomas M. Prescott
|
100
|
%
|
|
Kenneth B. Arola
|
60
|
%
|
|
Len M. Hedge
|
70
|
%
|
|
Jennifer M. Erfurth
|
60
|
%
|
|
Richard Twomey
|
60
|
%
|
|
Dana C. Cambra
|
60
|
%
|
|
Measure/Weight/Calculated
|
|
Why do we use this
measure?
|
|
Target
|
|
Achievement
|
|
Level of
Achievement
of Target
|
|
Impact on
Company
Multiplier
|
||
|
Adjusted Revenue (1)(2) (40%)
|
|
Improvement in this measure aligns with our overall growth strategy.
|
|
$560.5M
|
|
$555.1M
|
|
99
|
%
|
|
39.2
|
%
|
|
Adjusted Operating income (1) (3) (30%)
|
|
Directly links incentive payments to Company profitability and we want our employees (including our executives) to share in our profitability. Because profitability encompasses both revenue and expense management, the Compensation Committee believes this measure encourages a balanced, holistic approach by our executives to manage our business. The Compensation Committee considers operating profit before taxes because our executives cannot predict or directly affect our taxes or our tax rate.
|
|
$150.6M
|
|
$146.9M
|
|
98
|
%
|
|
28.5
|
%
|
|
Roadmap Elements (30%)
Delivering key elements of Company roadmap projects or initiatives, including meeting delivery dates and feature set requirements. (5)
|
|
Critical to our achievement of our multi-year strategic corporate priorities, specifically, increased adoption and frequency of use by our customers, the orthodontist and general practitioner dentist and increased consumer demand. (4)
|
|
|
|
|
|
109
|
%
|
|
32.7
|
%
|
|
COMPANY MULTIPLIER:
|
|
|
|
|
|
|
|
|
|
100.4
|
%
|
|
|
(1)
|
The threshold performance and the level of performance at which the funding for that particular performance measure will be capped as follows:
|
|
•
|
A rating of zero if achievement is below 80%. Company performance below target automatically reduces only the payout related to that goal, not the other goals, because we want executives to have the same incentive to achieve other financial goals as well as their individual performance goals even if our performance tracks below the target during the course of the year;
|
|
•
|
A rating ranging from 80% to 100% if achievement meets or exceeds the minimum performance level but does not achieve the target performance level; and
|
|
•
|
A rating of 101% to 200% if achievement meets or exceeds the target performance level.
|
|
(2)
|
Adjusted Revenue was adjusted to exclude $4.9 million of previously deferred revenue from case refinements.
|
|
(3)
|
Adjusted Operating Income was adjusted to exclude (A) stock based compensation expense; (B) severance costs; (C) amortization of intangibles; and (D) impairment of goodwill.
|
|
(a)
|
Stock based compensation expense;
|
|
(b)
|
significant and/or extraordinary items that are not indicative of our core operating performance that are separately stated on our financial statements;
|
|
(c)
|
items identified as non-GAAP in the Company’s quarterly earnings announcements; and
|
|
(d)
|
other discrete items as necessary that may result in unintended gain or loss under the bonus plan.
|
|
Name
|
Target
Incentive
Award (as %
of Base Salary)
|
|
Target
Incentive
Award (1)
|
|
Actual
Incentive
Award
|
|
Actual
Award as
% of
Target
|
||||||
|
Thomas M. Prescott
|
100
|
%
|
|
$
|
615,000
|
|
|
$
|
650,000
|
|
|
106
|
%
|
|
Kenneth B. Arola
|
60
|
%
|
|
$
|
204,161
|
|
|
$
|
204,978
|
|
|
100
|
%
|
|
Len M. Hedge
|
70
|
%
|
|
$
|
262,762
|
|
|
$
|
341,451
|
|
|
129
|
%
|
|
Jennifer M. Erfurth
|
60
|
%
|
|
$
|
48,000
|
|
|
$
|
58,192
|
|
|
121
|
%
|
|
Richard Twomey
|
60
|
%
|
|
$
|
199,770
|
|
|
$
|
235,627
|
|
|
118
|
%
|
|
Dana C. Cambra (2)
|
60
|
%
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
||
|
(1)
|
The amount shown for Ms. Erfurth is pro rated based on the number of days she was employed in 2012.
|
|
(2)
|
Mr. Cambra left the company in December 2012 prior to the awarding of annual cash incentive awards. He was, however, entitled to severance payments tied in part to his bonus for 2012. You can find more information about these payments below under the heading “Post-Employment Benefits for Dana Cambra”.
|
|
Award Type
|
Rationale for 2012 portfolio
|
|
Why discontinue stock options?
|
Based on our continuous review of our equity portfolio, the Compensation Committee did not grant options to executive officers in 2012 in order to focus more heavily on performance based MSUs which we believe will further align the compensation of our NEOs with Company performance and stockholders’ interests, and time-based RSUs to promote retention of our leadership team.
|
|
|
|
|
Why RSUs?
|
We believe RSUs provide an incentive to reward retention (even in the event of a decline in Align’s share price) and growth in value of Align’s stock. In addition, RSUs enable our executives to accumulate stock ownership in the Company.
|
|
|
|
|
Why MSUs?
|
We believe MSUs provide a vehicle that has more consistent value delivery compared to options but also has a direct link to long-term interests of stockholders by rewarding executives for Align’s performance measured
in relation
to other companies over a specified period. The actual number of shares of our common stock issuable under MSUs is variable based on over-or under-performance of Align’s stock price compared to the Nasdaq Composite Index during the 3-year performance period. If Align under-performs the NASDAQ Composite Index, the percentage at which the MSUs convert into shares of Align stock will be reduced from 100%, at a rate of two to one (two-percentage-point reduction in units for each percentage point of under-performance), with a minimum percentage of 0%. This means that no shares will vest if Align underperforms the NASDAQ Composite by 50 percentage points. If Align outperforms the NASDAQ Composite Index, the percentage at which the MSUs convert to shares will be increased from 100%, at a rate of two to one (two-percentage-point increase in units for each percentage point of over-performance), with a maximum percentage of 150%. This means that if Align outperforms the NASDAQ Composite by 25 percentage points, the maximum number of shares that will vest is 150% of the award amount. For instance, if the Nasdaq Composite index increased by 10% over the performance period and our stock price increased by 30% over the performance period, then the number of shares issuable under the MSUs would be 140% of target or (130%-110%)*2=140%.
|
|
|
Vesting Detail
|
|
|
|
|
RSUs
|
Vests over 4 years with 1/4 vesting annually.
|
|
|
|
|
MSUs
|
Three year performance period beginning February 2012 and ending February 2015; 100% vests February 2015.
|
|
Name
|
|
RSUs
|
|
Target
MSUs(1)
|
||
|
Thomas M. Prescott
|
|
62,500
|
|
|
62,500
|
|
|
Kenneth B. Arola
|
|
16,200
|
|
|
16,200
|
|
|
Len M. Hedge
|
|
24,000
|
|
|
24,000
|
|
|
Jennifer M. Erfurth (2)
|
|
40,000
|
|
|
N/A
|
|
|
Richard Twomey
|
|
16,500
|
|
|
16,500
|
|
|
Dana C. Cambra
|
|
17,250
|
|
|
17,250
|
|
|
(1)
|
The number of MSUs set forth in this column represents the Target Shares. However, the actual number of MSUs to be received, if any, is determined based on the formula set forth in the Market Stock Unit Agreement up to a maximum of 150% of the amount of the Target Shares.
|
|
(2)
|
As part of Ms. Erfurth's employment offer, and upon commencement of her employment with us, she was awarded 40,000 RSUs. Such “new hire” awards are typically larger than annual grants and do not include MSUs.
|
|
•
|
a change of control; and
|
|
•
|
termination without cause or for convenience.
|
|
THE COMPENSATION COMMITTEE
|
|
David E. Collins
|
|
George J. Morrow, Chair
|
|
David C. Nagel
|
|
Name and Principal
Position
|
|
Year
|
|
Salary
($)
|
|
Bonus ($) (1)
|
Stock
Awards ($)
(2)
|
|
Option
Awards
($)(2)
|
|
Non-Equity
Incentive Plan
Compensation
($)
|
|
All Other
Compensation ($)
|
|
Total ($)
|
|||||||
|
Thomas M. Prescott,
President & Chief Executive Officer
|
|
2012
|
|
610,385
|
|
|
—
|
|
3,541,875
|
|
|
—
|
|
|
650,000
|
|
|
13,022
|
|
|
4,815,282
|
|
|
2011
|
|
570,961
|
|
|
—
|
|
1,930,950
|
|
|
933,246
|
|
|
950,000
|
|
|
11,707
|
|
|
4,396,864
|
|
||
|
2010
|
|
537,674
|
|
|
—
|
|
1,076,400
|
|
|
1,617,350
|
|
|
800,000
|
|
|
10,518
|
|
|
4,041,942
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Kenneth B. Arola,
Vice President & Chief Financial Officer (3)
|
|
2012
|
|
338,735
|
|
|
—
|
|
918,054
|
|
|
—
|
|
|
204,978
|
|
|
8,194
|
|
|
1,469,961
|
|
|
2011
|
|
323,858
|
|
|
—
|
|
514,920
|
|
|
223,979
|
|
|
290,538
|
|
|
8,017
|
|
|
1,361,312
|
|
||
|
2010
|
|
297,115
|
|
|
—
|
|
287,040
|
|
|
443,616
|
|
|
233,816
|
|
|
7,536
|
|
|
1,269,123
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Len M. Hedge,
Sr. Vice President, Business Operations (4)
|
|
2012
|
|
373,621
|
|
|
—
|
|
1,360,080
|
|
|
—
|
|
|
341,451
|
|
|
8,214
|
|
|
2,083,366
|
|
|
2011
|
|
357,621
|
|
|
—
|
|
720,888
|
|
|
293,454
|
|
|
397,707
|
|
|
8,064
|
|
|
1,777,734
|
|
||
|
2010
|
|
335,346
|
|
|
—
|
|
358,800
|
|
|
554,520
|
|
|
327,445
|
|
|
8,040
|
|
|
1,584,151
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Richard Twomey,
VicePresident, International
|
|
2012
|
|
331,185
|
|
|
—
|
|
935,055
|
|
|
—
|
|
|
235,627
|
|
|
42,917
|
|
|
1,544,784
|
|
|
|
2011
|
|
316,878
|
|
|
—
|
|
257,460
|
|
|
129,618
|
|
|
298,535
|
|
|
291,047
|
|
|
1,293,538
|
|
|
|
|
2010
|
|
144,608
|
|
|
—
|
|
428,100
|
|
|
655,371
|
|
|
117,797
|
|
|
73,282
|
|
|
1,419,158
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Jennifer M. Erfurth,
Vice President, Global Human Resources
|
|
2012
|
|
67,692
|
|
|
385,000
|
|
1,056,800
|
|
|
—
|
|
|
58,192
|
|
|
85,672
|
|
|
1,653,356
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Dana C. Cambra,
Former Vice President, Research & Development and Information Technology (5) |
|
2012
|
|
340,971
|
|
|
—
|
|
977,558
|
|
|
—
|
|
|
—
|
|
|
2,029,017
|
|
|
3,347,546
|
|
|
2011
|
|
329,150
|
|
|
—
|
|
570,703
|
|
|
233,312
|
|
|
322,870
|
|
|
8,026
|
|
|
1,464,061
|
|
||
|
|
2010
|
|
310,948
|
|
|
—
|
|
245,186
|
|
|
378,922
|
|
|
265,264
|
|
|
17,194
|
|
|
1,217,514
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
(1)
|
This amount reflects a one-time sign-on bonus paid to Ms. Erfurth in connection with her commencement of employment with the Company on October 1, 2012. Pursuant to the terms of her employment agreement, Ms. Erfurth has agreed that should she voluntarily leave the Company or is terminated without cause prior to October 1, 2013 she will will return 100% of the sign-on bonus. If she voluntarily leaves or is terminated without cause on or after October 1, 2013, for each month of full time employment, the Company shall forgive 1/24th of the sign on bonus and the remaining unforgiven amount will be due and payable to the Company on demand.
|
|
(2)
|
The amounts shown in this column reflect the aggregate grant date fair value computed in accordance with FASB ASC Topic 718. Assumptions used in the calculations of these amounts are included in Note 10 to our audited financial statements for the year ended December 31, 2012 included in the Company’s Annual Report on Form 10-K filed with the SEC on March 1, 2013. This same method was used for years ended December 31, 2011 and 2010. There can be no assurance that the grant date fair value amounts will ever be realized.
|
|
(3)
|
Mr. Arola's tenure as CFO ended on March 4, 2013. He will remain an employee of the Company until June 2013.
|
|
(4)
|
In May 2012, Mr. Hedge announced his intention to retire in February 2013.
|
|
(5)
|
Dana Cambra, Align’s then current Vice President, Research & Development and Information Technology left Align effective December 5, 2012. In connection with his departure, Align and Mr. Cambra entered into an Agreement and General Release that provided Mr. Cambra would receive certain benefits in accordance with his Employment Agreement, including (i) 12 months of his base salary, (ii) the greater of his current year’s bonus or the prior year’s actual bonus, (iii) the pro rata amount of the current year’s bonus, and (iv) acceleration of vesting of a portion of his outstanding equity awards. In addition, Ms. Cambra received his accrued but unpaid vacation. Each of these amounts is included in “All Other Compensation” in the table above and described more fully below.
|
|
Name
|
|
Dollar
Value of
Life
Insurance
Premiums
|
|
Matching
contributions
under Align’s
401(k) Plan
|
|
Relocation Expense Reimbursement & Temporary Housing (1)
|
|
Airfare
for
Family
Members
|
|
Severance and Other
Post-Employment
Compensation(2)
|
||||||||||
|
Mr. Prescott
|
|
$
|
714
|
|
|
$
|
7,500
|
|
|
—
|
|
|
$
|
4,808
|
|
|
—
|
|
||
|
Mr. Arola
|
|
$
|
694
|
|
|
$
|
7,500
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Mr. Hedge
|
|
$
|
714
|
|
|
$
|
7,500
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Mr. Twomey
|
|
$
|
679
|
|
|
$
|
7,500
|
|
|
$
|
34,738
|
|
|
—
|
|
|
—
|
|
||
|
Ms. Erfurth
|
|
$
|
270
|
|
|
$
|
5,687
|
|
|
$
|
79,715
|
|
|
—
|
|
|
—
|
|
||
|
Mr. Cambra
|
|
$
|
714
|
|
|
$
|
7,500
|
|
|
—
|
|
|
—
|
|
|
$
|
2,020,803
|
|
||
|
(1)
|
The amount for Mr. Twomey is for relocation expenses associated with his move from the United Kingdom to the Bay Area. For Ms. Erfurth, the amount reflects $62,015 of relocation expenses (including home sale assistance) and $17,700 for temporary housing associated with her move from Utah to the Bay Area.
|
|
(2)
|
For Mr. Cambra, this amount includes (i) $905,434 cash severance, (ii) $1,075,006 related to estimated realized value for accelerated equity assuming the exercise and/or sale on December 31, 2012 at $27.75 per share, and (iii) $40,363 for accrued vacation time.
|
|
•
|
cash amounts that could have been received in 2012 by our NEOs under the terms of our performance-based cash incentive plan (CIP); and
|
|
•
|
time-vested restricted stock units (RSUs) and performance-based market stock units based on relative stockholder return (MSUs) awards granted by the Compensation Committee to our NEOs in 2012 reflected on an individual grant basis.
|
|
|
Type
of
Award
|
|
Grant
Date
|
|
Approval
Date
|
|
Estimated
Future
Payouts
Under
Non-Equity
Incentive
Awards
|
|
Estimated Future
Payouts Under
Equity Incentive
Awards
|
|
All
Other
Stock
Awards:
Number
of
Shares
of Stock
or Units
(#)
|
|
Grant Date
Fair value
of Options
and
Awards ($)
|
|||||||||
|
Name
|
Target
($)
|
|
Target
(#)
|
|
Maximum
(#)
|
|
||||||||||||||||
|
Thomas M. Prescott
|
CIP
|
|
|
|
|
|
$
|
615,000
|
|
|
|
|
|
|
|
|
|
|||||
|
RSU
|
|
2/20/2012
|
|
1/31/2012
|
|
|
|
|
|
|
|
62,500
|
|
|
$
|
1,701,250
|
|
|||||
|
MSU
|
|
2/20/2012
|
|
1/31/2012
|
|
|
|
62,500
|
|
|
93,750
|
|
|
|
|
$
|
1,840,625
|
|
||||
|
Kenneth B. Arola
|
CIP
|
|
|
|
|
|
$
|
204,161
|
|
|
|
|
|
|
|
|
|
|||||
|
RSU
|
|
2/20/2012
|
|
1/31/2012
|
|
|
|
|
|
|
|
16,200
|
|
|
$
|
440,964
|
|
|||||
|
MSU
|
|
2/20/2012
|
|
1/31/2012
|
|
|
|
16,200
|
|
|
24,300
|
|
|
|
|
$
|
477,090
|
|
||||
|
Len M. Hedge
|
CIP
|
|
|
|
|
|
$
|
262,762
|
|
|
|
|
|
|
24,000
|
|
|
|
||||
|
RSU
|
|
2/20/2012
|
|
1/31/2012
|
|
|
|
|
|
|
|
|
|
$
|
653,280
|
|
||||||
|
MSU
|
|
2/20/2012
|
|
1/31/2012
|
|
|
|
24,000
|
|
|
36,000
|
|
|
|
|
$
|
706,800
|
|
||||
|
Dana C. Cambra
|
CIP
|
|
|
|
|
|
$
|
209,887
|
|
|
|
|
|
|
|
|
|
|||||
|
RSU
|
|
2/20/2012
|
|
1/31/2012
|
|
|
|
|
|
|
|
17,250
|
|
|
$
|
469,545
|
|
|||||
|
MSU
|
|
2/20/2012
|
|
1/31/2012
|
|
|
|
17,250
|
|
|
25,875
|
|
|
|
|
$
|
508,013
|
|
||||
|
Richard Twomey
|
CIP
|
|
|
|
|
|
$
|
199,770
|
|
|
|
|
|
|
|
|
|
|||||
|
RSU
|
|
2/20/2012
|
|
1/31/2012
|
|
|
|
|
|
|
|
16,500
|
|
|
$
|
449,130
|
|
|||||
|
MSU
|
|
2/20/2012
|
|
1/31/2012
|
|
|
|
16,500
|
|
|
24,750
|
|
|
|
|
$
|
185,925
|
|
||||
|
Jennifer M. Erfurth
|
CIP
|
|
|
|
|
|
$
|
48,000
|
|
|
|
|
|
|
|
|
|
|||||
|
RSU
|
|
10/24/2012
|
|
10/24/2012
|
|
|
|
|
|
|
|
40,000
|
|
|
$
|
1,056,800
|
|
|||||
|
•
|
Threshold.
There is no threshold performance level. Rather, company performance below a specific target automatically reduces only the payout related to that specific goal, not the other goals, because we want executives to have the same incentive to achieve strategic priorities as well as their individual performance goals even if our financial performance tracks below the target during the course of the year.
|
|
•
|
Target.
The target amounts assume a corporate performance percentage of 100% and that the NEO received 100% of his target.
|
|
•
|
Maximum.
Although each financial objective is capped at 200% for funding the total pool available for distribution, there is no maximum amount that an NEO could receive.
|
|
•
|
Align does not plan to time, nor has it timed, the release of material non-public information for the purpose of affecting the exercise price of its stock options;
|
|
•
|
consistent with the policy described in the bullet point above, all awards of equity compensation for new employees (other than new executive officers described in the next bullet point) are made on the first day of the month for those employees who started during the period between the 16
th
day of the month that is two months prior to the grant date and the 15
th
day of the month prior to the month of the grant date. For example, May 1, 2013 grants will cover new hires starting between March 16, 2013 and April 15, 2013; and
|
|
•
|
annual incentive grants are made on or about the same day for all employees (including executive officers); in fiscal 2012 such date was February 20. The Compensation Committee sets the actual grant date approximately one week following approval of the size of each grant in order to provide Align managers with adequate time to inform each employee individually of their grant.
|
|
Name
|
Option Awards
|
|
Stock Awards
|
|||||||||||||||||||||||||||||||||
|
Number of
securities
underlying
unexercised
options (#)
Exercisable
|
|
F
o
o
t
n
o
t
e
|
|
Number of
securities
underlying
unexercised
options (#)
Unexercisable
|
|
F
o
o
t
n
o
t
e
|
|
Equity
Incentive
Plan
Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options (#)
|
|
Option
Exercise
Price
($)
|
|
Option
Expiration
Date
|
|
Number
of
Shares
or Units
of Stock
That
Have
Not
Vested
(#)
|
|
F
o
o
t
n
o
t
e
|
|
Market
Value of
Shares
or Units
of Stock
That
Have
Not
Vested
($)
|
|
Equity
Incentive
Plan
Awards:
Number
of
Unearned
Shares,
Units or
Other
Rights
that have
Not
Vested
(#)
|
|
F
o
o
t
n
o
t
e
|
|
Equity
Incentive
Plan
Awards:
Market
or Payout
Value of
Unearned
Shares,
Units or
Other
Rights
That
Have Not
Vested
($)
|
||||||||||||
|
Thomas M. Prescott
|
150,000
|
|
|
|
|
—
|
|
|
|
|
|
|
18.73
|
|
|
3/12/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
120,000
|
|
|
|
|
—
|
|
|
|
|
|
|
17.88
|
|
|
2/20/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
130,000
|
|
|
|
|
|
|
|
|
|
|
13.00
|
|
|
2/20/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
140,000
|
|
|
|
|
|
|
|
|
|
|
13.00
|
|
|
2/20/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
111,645
|
|
|
|
|
4,855
|
|
|
(1
|
)
|
|
|
|
7.81
|
|
|
2/20/2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
123,958
|
|
|
|
|
51,042
|
|
|
(3
|
)
|
|
|
|
17.94
|
|
|
2/19/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
41,250
|
|
|
|
|
48,750
|
|
|
(5
|
)
|
|
|
|
20.79
|
|
|
2/18/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
|
|
(2
|
)
|
|
277,500
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000
|
|
|
(4
|
)
|
|
832,500
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000
|
|
|
(6
|
)
|
|
832,500
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
62,500
|
|
|
(8
|
)
|
|
1,734,375
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45,000
|
|
|
(7
|
)
|
|
1,248,750
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
62,500
|
|
|
(9
|
)
|
|
1,734,375
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Kenneth B. Arola
|
18,500
|
|
|
|
|
|
|
|
|
|
|
17.88
|
|
|
2/20/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
75,000
|
|
|
|
|
|
|
|
|
|
|
17.77
|
|
|
12/14/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
2,865
|
|
|
|
|
1,146
|
|
|
(1
|
)
|
|
|
|
7.81
|
|
|
2/20/2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
34,000
|
|
|
|
|
14,000
|
|
|
(3
|
)
|
|
|
|
17.94
|
|
|
2/19/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
9,900
|
|
|
|
|
11,700
|
|
|
(5
|
)
|
|
|
|
20.79
|
|
|
2/18/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,291
|
|
|
(2
|
)
|
|
63,575
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,000
|
|
|
(4
|
)
|
|
222,000
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,000
|
|
|
(6
|
)
|
|
222,000
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,200
|
|
|
(8
|
)
|
|
449,550
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,000
|
|
|
(7
|
)
|
|
333,000
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,200
|
|
|
(9
|
)
|
|
449,550
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Len M. Hedge
|
32,959
|
|
|
|
|
|
|
|
|
|
|
8.38
|
|
|
2/24/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
6,476
|
|
|
|
|
|
|
|
|
|
|
17.88
|
|
|
2/20/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
3,740
|
|
|
|
|
|
|
|
|
|
|
17.77
|
|
|
12/14/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
39,000
|
|
|
|
|
|
|
|
|
|
|
13.00
|
|
|
2/20/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
20,000
|
|
|
|
|
|
|
|
|
|
|
13.00
|
|
|
2/20/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
40,623
|
|
|
|
|
1,767
|
|
|
(1
|
)
|
|
|
|
7.81
|
|
|
2/20/2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
42,500
|
|
|
|
|
17,500
|
|
|
(3
|
)
|
|
|
|
17.94
|
|
|
2/19/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
12,970
|
|
|
|
|
15,330
|
|
|
(5
|
)
|
|
|
|
20.79
|
|
|
2/18/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,532
|
|
|
(2
|
)
|
|
98,013
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
|
|
(4
|
)
|
|
277,500
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,200
|
|
|
(6
|
)
|
|
310,800
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,000
|
|
|
(8
|
)
|
|
666,000
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,800
|
|
|
(7
|
)
|
|
466,200
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,000
|
|
|
(9
|
)
|
|
666,000
|
|
||||||||
|
Name
|
Option Awards
|
|
Stock Awards
|
|||||||||||||||||||||||||||||||||
|
Number of
securities
underlying
unexercised
options (#)
Exercisable
|
|
F
o
o
t
n
o
t
e
|
|
Number of
securities
underlying
unexercised
options (#)
Unexercisable
|
|
F
o
o
t
n
o
t
e
|
|
Equity
Incentive
Plan
Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options (#)
|
|
Option
Exercise
Price
($)
|
|
Option
Expiration
Date
|
|
Number
of
Shares
or Units
of Stock
That
Have
Not
Vested
(#)
|
|
F
o
o
t
n
o
t
e
|
|
Market
Value
of
Shares
or
Units
of
Stock
That
Have
Not
Vested
($)
|
|
Equity
Incentive
Plan
Awards:
Number
of
Unearned
Shares,
Units or
Other
Rights
that have
Not
Vested
(#)
|
|
F
o
o
t
n
o
t
e
|
|
Equity
Incentive
Plan
Awards:
Market
or Payout
Value of
Unearned
Shares,
Units or
Other
Rights
That
Have Not
Vested
($)
|
||||||||||||
|
Dana C. Cambra
|
7,917
|
|
|
|
|
|
|
|
|
|
|
12.25
|
|
|
6/16/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
7,584
|
|
|
|
|
|
|
|
|
|
|
7.81
|
|
|
2/20/2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
18,792
|
|
|
|
|
|
|
|
|
|
|
17.94
|
|
|
2/19/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
15,468
|
|
|
|
|
|
|
|
|
|
|
20.79
|
|
|
2/19/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Richard Twomey
|
3,750
|
|
|
|
|
35,625
|
|
|
(11
|
)
|
|
|
|
14.27
|
|
|
7/12/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
521
|
|
|
|
|
6,771
|
|
|
(5
|
)
|
|
|
|
20.79
|
|
|
2/18/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000
|
|
|
(12
|
)
|
|
416,250
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,000
|
|
|
(6
|
)
|
|
111,000
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,500
|
|
|
(8
|
)
|
|
457,875
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,000
|
|
|
(7
|
)
|
|
166,500
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,500
|
|
|
(9
|
)
|
|
457,875
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Jennifer M. Erfurth
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,000
|
|
|
(10
|
)
|
|
1,110,000
|
|
|
|
|
|
|
|
||||||||
|
(1)
|
25% of the shares subject to this option vest on 2/20/2010 with 1/48th vesting monthly thereafter for full vesting on 2/20/2013.
|
|
(2)
|
Restricted stock units vest at a rate of 25% of the total number of shares subject to the restricted stock unit on the first year, second year, third year and fourth year anniversary of the date of grant for vesting on 02/20/2010, 02/20/2011, 02/20/2012 and 02/20/2013.
|
|
(3)
|
25% of the shares subject to this option vest on 02/19/11 with 1/48th vesting monthly thereafter for full vesting on 02/19/14.
|
|
(4)
|
Restricted stock units vest at a rate of 25% of the total number of shares subject to the restricted stock unit on the first year, second year, third year and fourth year anniversary of the date of grant for vesting on 02/19/2011, 02/19/2012, 02/19/2013 and 02/19/2014.
|
|
(5)
|
25% of the shares subject to this option vest on 2/20/2012 with 1/48th vesting monthly thereafter for full vesting on 2/20/2015.
|
|
(6)
|
Restricted stock units vest at a rate of 33.33% of the total number of shares subject to the restricted stock unit on the first year, second year, and third year anniversary of the date of grant for vesting on 02/18/2012, 02/18/2013, and 02/18/2014.
|
|
(7)
|
Market stock units vest at a rate of 50% on 2/18/13 and 50% on 2/18/14 for full vesting at the end of the three-year performance cycle.
|
|
(8)
|
Restricted stock units vest at a rate of 25% of the total number of shares subject to the restricted stock unit on the first year, second year, third year and fourth year anniversary of the date of grant for vesting on 02/20/2013, 02/20/2014, 02/20/2015 and 02/20/2016.
|
|
(9)
|
Market stock units vest at a rate of 100% on 2/20/15 for full vesting at the end of the three-year performance cycle.
|
|
(10)
|
Restricted stock units vest at a rate of 25% of the total number of shares subject to the restricted stock unit on the first year, second year, third year, and fourth year anniversary for vesting on 11/20/13, 11/20/14, 11/20/15, and 11/20/16.
|
|
(11)
|
25% of the shares subject to this option vest on 7/12/11 with 1/48th vesting monthly thereafter for full vesting on 7/12/14.
|
|
(12)
|
Restricted stock units vest at a rate of 25% of the total number of shares subject to the restricted stock units on the first year, second year, third year, and fourth year anniversary for vesting on 07/20/11, 07/20/12, 07/20/13, and 07/20/14.
|
|
|
Option Awards
|
|
Stock Awards
|
||||||||||
|
Name
|
Number of
Shares
Acquired
on Exercise
|
|
Value
Realized
Upon
Exercise (1)
|
|
Number of
Shares
Acquired
on Vesting (2)
|
|
Value
Realized
on
Vesting (3)
|
||||||
|
Thomas M. Prescott
|
282,869
|
|
|
$
|
5,003,058
|
|
|
52,000
|
|
|
$
|
1,415,440
|
|
|
Kenneth B. Arola
|
92,489
|
|
|
$
|
2,076,742
|
|
|
12,292
|
|
|
$
|
334,836
|
|
|
Len M. Hedge
|
257,575
|
|
|
$
|
4,360,274
|
|
|
16,132
|
|
|
$
|
439,113
|
|
|
Richard Twomey
|
27,833
|
|
|
$
|
412,791
|
|
|
9,500
|
|
|
$
|
310,790
|
|
|
Dana C. Cambra (4)
|
47,250
|
|
|
$
|
548,213
|
|
|
50,881
|
|
|
$
|
1,366,786
|
|
|
(1)
|
The value realized on exercise equals the difference between (a) either (i) the actual sales price of our common stock underlying the options exercised if the shares were immediately sold or (ii) the closing price per share of our common stock as reported on the NASDAQ Global Market on the date of exercise if the shares were held and (b) the applicable exercise price of such stock options.
|
|
(2)
|
For each NEO such number of shares represents the gross number of shares acquired by the NEO on the vesting date. However, because RSUs are taxable to the individuals when they vest, the number of shares we issue to each of our named executive officers is net of applicable withholding taxes which are paid by us on their behalf. Except for as described in footnote (4) below, no MSUs vested in 2011.
|
|
(3)
|
The value realized on vesting equals the closing price per share of our common stock as reported on the NASDAQ Global Market on the vesting date multiplied by the gross number of shares acquired on vesting as described above in note (2).
|
|
(4)
|
In connection with Ms. Cambra’s departure in December 2012, Align and Mr. Cambra entered into an Agreement and General Release that provided Mr. Cambra would receive certain benefits in accordance with his Employment Agreement, including 12 months acceleration of vesting on
her outstanding equity awards. As a result, the amounts in the table above include the effect of the acceleration of 14,496 RSUs and 17,951 MSUs. None of the 17,625 shares subject to options that were also accelerated were exercised by December 31, 2012.
|
|
|
|||||||||||||
|
Name
|
Type of Payment
|
|
Payments Upon
Involuntary or Good
Reason Termination
Unrelated to Change
of Control
|
|
Payments Upon
Involuntary or
Good Reason
Termination
Related to a
Change of
Control
|
|
Change of
Control Only
|
||||||
|
Kenneth B. Arola
|
Severance Payment
|
|
$
|
834,968
|
|
|
$
|
834,968
|
|
|
—
|
|
|
|
|
Equity
|
|
|
|
|
|
|
||||||
|
|
Stock Options
|
|
$
|
178,155
|
|
|
$
|
241,623
|
|
|
$
|
178,155
|
|
|
|
Restricted Stock Units
|
|
$
|
397,963
|
|
|
$
|
619,963
|
|
|
$
|
397,963
|
|
|
|
Market Stock Units
|
|
$
|
287,651
|
|
|
$
|
1,002,996
|
|
|
$
|
287,651
|
|
|
|
Health and Welfare Benefits
|
|
$
|
17,810
|
|
|
$
|
17,810
|
|
|
—
|
|
|
|
|
Total
|
|
$
|
1,716,547
|
|
|
$
|
2,717,360
|
|
|
$
|
863,769
|
|
|
Len M. Hedge
|
Severance Payment
|
|
$
|
1,035,843
|
|
|
$
|
1,035,843
|
|
|
—
|
|
|
|
|
Equity
|
|
|
|
|
|
|
||||||
|
|
Stock Options
|
|
$
|
231,626
|
|
|
$
|
313,606
|
|
|
$
|
231,626
|
|
|
|
Restricted Stock Units
|
|
$
|
558,663
|
|
|
$
|
852,813
|
|
|
$
|
558,663
|
|
|
|
Market Stock Units
|
|
$
|
414,441
|
|
|
$
|
1,445,220
|
|
|
$
|
414,441
|
|
|
|
Health and Welfare Benefits
|
|
$
|
28,876
|
|
|
28,876
|
|
|
—
|
|
||
|
|
Total
|
|
$
|
2,269,449
|
|
|
$
|
3,676,358
|
|
|
$
|
1,204,730
|
|
|
Jennifer Erfurth
|
Severance Payment
|
|
$
|
560,000
|
|
|
$
|
560,000
|
|
|
—
|
|
|
|
|
Equity
|
|
|
|
|
|
|
||||||
|
|
Stock Options (Ms. Erfurth was not granted stock options)
|
|
n/a
|
|
|
n/a
|
|
|
n/a
|
|
|||
|
|
Restricted Stock Units
|
|
$
|
277,500
|
|
|
$
|
1,110,000
|
|
|
277,500
|
|
|
|
|
Market Stock Units (Ms. Erfurth was not granted MSUs)
|
|
n/a
|
|
|
n/a
|
|
|
n/a
|
|
|||
|
|
Health and Welfare Benefits
|
|
$
|
22,847
|
|
|
$
|
22,847
|
|
|
—
|
|
|
|
|
Total
|
|
$
|
860,347
|
|
|
$
|
1,692,847
|
|
|
$
|
277,500
|
|
|
Richard Twomey
|
Severance Payment
|
|
$
|
831,257
|
|
|
$
|
831,257
|
|
|
—
|
|
|
|
|
Equity
|
|
|
|
|
|
|
||||||
|
|
Stock Options
|
|
$
|
325,050
|
|
|
$
|
527,351
|
|
|
325,050
|
|
|
|
|
Restricted Stock Units
|
|
$
|
378,094
|
|
|
$
|
985,125
|
|
|
378,094
|
|
|
|
|
Market Stock Units
|
|
$
|
218,464
|
|
|
$
|
762,570
|
|
|
218,464
|
|
|
|
|
Health and Welfare Benefits
|
|
$
|
25,888
|
|
|
$
|
25,888
|
|
|
—
|
|
|
|
|
Total
|
|
$
|
1,778,753
|
|
|
$
|
3,132,191
|
|
|
$
|
921,608
|
|
|
Dana Cambra (1)
|
|
|
|
|
|
|
|
||||||
|
(1)
|
Mr. Cambra was no longer employed by Align as of December 31, 2012. See “Summary Compensation Table for Fiscal Year Ended 2012” for further information regarding the post-employment benefits actually paid to Mr. Cambra in 2012 under “All Other Compensation”.
|
|
(i)
|
if Align under-performs the Nasdaq Composite index, the percentage at which the MSUs convert into shares of Align stock will be reduced from 100% at a rate of two to one (two-percentage-point reduction in units for each percentage point of under-performance); and
|
|
(ii)
|
if Align outperforms the index, the percentage at which the MSUs convert to shares will be increased from 100% at a rate of two to one (two-percentage-point increase in units for each percentage point of over-performance).
|
|
(i)
|
the then current annual base salary;
|
|
(ii)
|
the then current year’s target bonus, prorated for the number of days such executive has been employed during the year; and
|
|
(iii)
|
the greater of the then current year’s target bonus or the prior year’s actual bonus.
|
|
•
|
the performance period shall be deemed to end upon the closing of the change of control in order to determine Align’s stock price performance relative to the Nasdaq Composite index for the purpose of calculating the amount that Align has over or underperformed the Nasdaq Composite index (with the MSUs converting into shares of Align stock either being reduced from 100% (in the case of underperformance) or increased from 100% (in the case of overperformance) at a rate of two to one (the “Performance Multiplier”); and
|
|
•
|
Align’s stock price performance will be based on the per share value of the Company’s common stock paid to its stockholders in connection with the change of control.
|
|
(1)
|
immediately vest in all outstanding equity awards; and
|
|
(2)
|
be entitled to a payment (payable in a lump sum) equal to:
|
|
(i)
|
executive’s then current annual base salary;
|
|
(ii)
|
executive’s then current year’s target bonus prorated for the number of days employed during the year, and
|
|
(iii)
|
the greater of the then current year’s target bonus or the prior year’s actual bonus.
|
|
Name
|
Type of Payment
|
|
Payments Upon
Involuntary or Good
Reason Termination
Unrelated to
Change of Control
|
|
Payments Upon
Involuntary or
Good Reason
Termination
Related to a
Change of
Control
|
|
Change of
Control
Only
|
||||||
|
Thomas M. Prescott
|
Severance Payment
|
|
$
|
2,795,000
|
|
|
$
|
2,795,000
|
|
|
$
|
—
|
|
|
|
Equity
|
|
|
|
|
|
|
||||||
|
|
Stock Options
|
|
—
|
|
|
936,831
|
|
|
936,831
|
|
|||
|
|
Restricted Stock Units
|
|
—
|
|
|
3,676,875
|
|
|
3,676,875
|
|
|||
|
|
Market Stock Units
|
|
—
|
|
|
1,943,714
|
|
|
1,943,714
|
|
|||
|
|
Health and Welfare Benefits
|
|
29,797
|
|
|
29,797
|
|
|
—
|
|
|||
|
|
Total
|
|
$
|
2,824,797
|
|
|
$
|
9,382,217
|
|
|
$
|
6,557,420
|
|
|
(1)
|
twice his then current annual base salary;
|
|
(2)
|
the then current year’s target bonus, prorated for the number of days Mr. Prescott has been employed during the year; and
|
|
(3)
|
the greater of 150% of the then current year’s target bonus or the prior year’s actual bonus.
|
|
(1)
|
twice his then current annual salary;
|
|
(2)
|
the then current year’s target bonus, prorated for the number of days Mr. Prescott has been employed during the year; and
|
|
(3)
|
the greater of 150% of the then current year’s target bonus or the prior year’s actual bonus.
|
|
•
|
unauthorized use or disclosure of the confidential information or trade secrets of Align;
|
|
•
|
any breach of the employment agreement or the Employee Proprietary Information and Inventions Agreement between the executive and Align;
|
|
•
|
conviction of, or a plea of “guilty” or “no contest” to, a felony under the laws of the United States or any state thereof;
|
|
•
|
misappropriation of the assets of Align or any act of fraud or embezzlement by the executive, or any act of dishonesty by the executive in connection with the performance of his or her duties for Align that adversely affects its business or affairs;
|
|
•
|
intentional misconduct; or
|
|
•
|
the executive’s failure to satisfactorily perform his or her duties after the executive received written notice of such failure and was provided at least thirty (30) days to cure such failure.
|
|
•
|
the executive’s position, authority or responsibilities being significantly reduced;
|
|
•
|
the executive being asked to relocate his principal place of employment such that the commuting distance from his or her residence prior to the change of control is increased by over thirty-five (35) miles;
|
|
•
|
the executive’s annual base salary or bonus being reduced; or
|
|
•
|
the executive’s benefits being materially reduced.
|
|
•
|
a sale of all or substantially all of Align’s assets;
|
|
•
|
the acquisition of more than 50% of the common stock of Align by any person or group of persons;
|
|
•
|
a reorganization of Align wherein the holders of common stock of Align receive stock in another company (other than a subsidiary of Align), a merger of Align with another company wherein there is a 50% or greater change in the ownership of the common stock of Align as a result of such merger, or any other transaction in which Align (other than as the parent corporation) is consolidated for federal income tax purposes or is eligible to be consolidated for federal income tax purposes with another corporation; or
|
|
•
|
in the event that the common stock is traded on an established securities market, a public announcement that any person has acquired or has the right to acquire beneficial ownership of more than 50% of the then outstanding common stock, or the commencement of or public announcement of an intention to make a tender offer or exchange offer for more than 50% of the then outstanding common stock.
|
|
•
|
each stockholder known by us to own beneficially more than 5% of our common stock;
|
|
•
|
each of our executive officers named in the summary compensation table on page 46 of this proxy statement;
|
|
•
|
each of our directors; and
|
|
•
|
all of our directors and executive officers as a group.
|
|
Name and Address
|
Number of
Outstanding
Shares
Beneficially
Owned
|
|
Number of
Shares
Underlying
Options
Exercisable
and RSUs
vesting on or
before May 21,
2013 (1)
|
|
Total Shares
Beneficially
Owned
|
|
Percentage of
Outstanding
Shares
Beneficially
Owned
|
||||
|
Danaher Corporation (2)
|
8,437,132
|
|
|
—
|
|
|
8,437,132
|
|
|
10.3
|
%
|
|
Gordon Gund, family members and affiliated entities (3)
|
7,259,150
|
|
|
—
|
|
|
7,259,150
|
|
|
8.9
|
%
|
|
FMR LLC (4)
|
7,156,000
|
|
|
—
|
|
|
7,156,000
|
|
|
8.8
|
%
|
|
Bank of New York Mellon Corporation (5)
|
6,345,043
|
|
|
—
|
|
|
6,345,043
|
|
|
7.8
|
%
|
|
BlackRock, Inc. (6)
|
5,650,098
|
|
|
—
|
|
|
5,650,098
|
|
|
6.9
|
%
|
|
Kornitzer Capital Management, Inc. (7)
|
5,638,800
|
|
|
—
|
|
|
5,638,800
|
|
|
6.9
|
%
|
|
Thomas M. Prescott
|
171,520
|
|
|
455,501
|
|
|
627,021
|
|
|
*
|
|
|
Kenneth B. Arola
|
31,682
|
|
|
148,661
|
|
|
180,343
|
|
|
*
|
|
|
Len M. Hedge
|
55,861
|
|
|
93,715
|
|
|
149,576
|
|
|
*
|
|
|
Jennifer Erfurth
|
—
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Richard Twomey
|
—
|
|
|
6,406
|
|
|
6,406
|
|
|
*
|
|
|
Dana Cambra
|
—
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
David Collins
|
16,500
|
|
|
—
|
|
|
16,500
|
|
|
*
|
|
|
Joseph Lacob (8)
|
746,962
|
|
|
48,000
|
|
|
794,962
|
|
|
1.0
|
%
|
|
C. Raymond Larkin, Jr.
|
39,660
|
|
|
98,000
|
|
|
137,660
|
|
|
*
|
|
|
George J. Morrow
|
20,000
|
|
|
125,000
|
|
|
145,000
|
|
|
*
|
|
|
David C. Nagel
|
6,000
|
|
|
50,000
|
|
|
56,000
|
|
|
*
|
|
|
Greg J. Santora
|
15,000
|
|
|
74,000
|
|
|
89,000
|
|
|
*
|
|
|
Warren S. Thaler (9)
|
178,034
|
|
|
20,000
|
|
|
198,034
|
|
|
*
|
|
|
All current executive officers and directors as a group (17 persons)
|
1,337,490
|
|
|
1,267,064
|
|
|
2,604,554
|
|
|
3.2
|
%
|
|
*
|
Less than 1%
|
|
(1)
|
Except as otherwise set forth in the footnotes below, represents shares of common stock that can be acquired upon the exercise of stock options and vesting of restricted stock units on or before May 21, 2013. This column includes the full amount of restricted stock units that will vest on or before May 21, 2013, although each executive officer will actually receive the number of shares that have vested net of the number of shares necessary to cover any applicable withholding taxes which Align will pay on their behalf.
|
|
(2)
|
Based on a filing with the Securities and Exchange Commission on Schedule 13D/A on February 22, 2011. The principal office of Danaher is located at 2099 Pennsylvania Avenue, N.W., 12
th
Floor, Washington, D.C. 20006.
|
|
(3)
|
Based on a filing with the Securities and Exchange Commission on Schedule 13G/A on February 13, 2013, indicating beneficial ownership as of December 31, 2012. Includes shares held in trust for immediate family members and shares held by immediate family members. The mailing address for Gordon Gund is P.O. box 449, Princeton, New Jersey 08542.
|
|
(4)
|
Based on a filing with the Securities and Exchange Commission on Schedule 13G on February 14, 2013, indicating beneficial ownership as of December 31, 2012. The principal office of FMR is located at 82 Devonshire Street, Boston MA 02109.
|
|
(5)
|
Based on a filing with the Securities and Exchange Commission on Schedule 13G/A, on February 4, 2013, indicating beneficial ownership as of December 31, 2013. Includes shares held by direct and indirect subsidiaries. The mailing address for The Bank of New York Mellon Corporation is One Wall Street, 31
st
Floor, New York, New York 10286.
|
|
(6)
|
Based on a filing with the Securities and Exchange Commission on Schedule 13G/A on February 6, 2013, indicating beneficial ownership as of December 31, 2012. Includes shares held by direct and indirect subsidiaries. The mailing address for BlackRock, Inc. is 40 East 52
nd
Street, New York, New York 10022.
|
|
(7)
|
Based on a filing with the Securities and Exchange Commission on Schedule 13G/A on January 24, 2013, indicating beneficial ownership as of December 31, 2012. The address for Kornitzer Capital Management Inc. is 5420 West 61
st
Place, Shawnee Mission, KS 66205.
|
|
(8)
|
Includes 598,195 shares held by the Joseph S. Lacob Trust and 148,767 shares held by Lacob Children’s Trust. Principal address is 2750 Sand Hill Road, Menlo Park, CA 94025.
|
|
(9)
|
Includes 72,450 shares held by Mr. Thaler and 105,584 shares held by The Thaler Family Trust, for the benefit of family members, as to which Mr. Thaler disclaims beneficial ownership.
|
|
•
|
you are a director or officer of Align and you desire to enter into a transaction with a Related Party (as defined above); or
|
|
•
|
you are an employee (other than a director or officer) and you desire to enter into a transaction with a Related Party that the Chief Financial Officer (in consultation with legal counsel) has deemed to be material to Align and is reportable under the rules and regulations of the Exchange Act,
|
|
THE BOARD OF
|
|
ALIGN TECHNOLOGY, INC.
|
|
|
|
April 18, 2013
|
|
|
Year Ended
|
||||||||||
|
|
December 31,
2012
|
|
|
December 31,
2011
|
|
|
December 31,
2010
|
|
|||
|
GAAP Profit from Operations
|
$
|
85,592
|
|
|
$
|
90,360
|
|
|
$
|
102,734
|
|
|
Teen deferred revenue release (1)
|
|
|
|
|
(14,298
|
)
|
|||||
|
Ormco royalties (2)
|
—
|
|
|
—
|
|
|
827
|
|
|||
|
Insurance settlement (3)
|
—
|
|
|
—
|
|
|
(8,666
|
)
|
|||
|
Litigation settlement (4)
|
—
|
|
|
—
|
|
|
4,549
|
|
|||
|
Acquisition and integration costs (5)
|
1,271
|
|
|
10,030
|
|
|
—
|
|
|||
|
Amortization of acquired intangible assets (6)
|
4,362
|
|
|
3,178
|
|
|
—
|
|
|||
|
Severance and benefit costs (7)
|
780
|
|
|
1,082
|
|
|
—
|
|
|||
|
Impairment of goodwill (8)
|
36,591
|
|
|
—
|
|
|
—
|
|
|||
|
Non-GAAP Profit from Operations
|
$
|
128,596
|
|
|
$
|
104,650
|
|
|
$
|
85,146
|
|
|
Reconciliation of GAAP to Non-GAAP Net Profit
|
|
|
|
|
|
||||||
|
(in thousands, except per share amounts)
|
|
|
|
|
|
||||||
|
|
Year Ended
|
||||||||||
|
|
December 31,
2012
|
|
|
December 31,
2011
|
|
|
December 31,
2010
|
|
|||
|
GAAP Net profit
|
$
|
58,691
|
|
|
$
|
66,716
|
|
|
$
|
74,253
|
|
|
Teen deferred revenue release (1)
|
—
|
|
|
—
|
|
|
(14,298
|
)
|
|||
|
Ormco royalties (2)
|
—
|
|
|
—
|
|
|
827
|
|
|||
|
Insurance settlement (3)
|
—
|
|
|
—
|
|
|
(8,666
|
)
|
|||
|
Litigation settlement (4)
|
—
|
|
|
—
|
|
|
4,549
|
|
|||
|
Acquisition and integration costs (5)
|
1,271
|
|
|
10,030
|
|
|
—
|
|
|||
|
Amortization of acquired intangible assets (6)
|
4,362
|
|
|
3,178
|
|
|
—
|
|
|||
|
Severance and benefit cost (7)
|
780
|
|
|
1,082
|
|
|
—
|
|
|||
|
Impairment of goodwill (8)
|
36,591
|
|
|
—
|
|
|
—
|
|
|||
|
Tax effect on non-GAAP adjustments (9)
|
(4,947
|
)
|
|
(2,862
|
)
|
|
5,631
|
|
|||
|
Non-GAAP Net profit
|
$
|
96,748
|
|
|
$
|
78,144
|
|
|
$
|
62,296
|
|
|
GAAP net profit per diluted share
|
$
|
0.71
|
|
|
$
|
0.83
|
|
|
$
|
0.95
|
|
|
Non-GAAP net profit per diluted share
|
$
|
1.17
|
|
|
$
|
0.97
|
|
|
$
|
0.80
|
|
|
Shares used in computing diluted GAAP net profit per share
|
83,040
|
|
|
80,294
|
|
|
78,080
|
|
|||
|
Shares used in computing diluted non-GAAP net profit per share
|
83,040
|
|
|
80,294
|
|
|
78,080
|
|
|||
|
(1)
|
Teen deferred revenue release. In the second quarter of 2010, we released $14.3 million of previously deferred revenue for Invisalign Teen replacement aligners. We excluded this non-recurring benefit as it is not indicative of future operating results.
|
|
(2)
|
Ormco Royalties. In 2010, we amortized royalty costs based on the litigation settlement agreement with Ormco. We excluded these costs as it is not indicative of future operating results.
|
|
(3)
|
Insurance Settlement. In June 2010, we received an $8.7 million insurance settlement over a disputed coverage under our general liability umbrella that was not previously reimbursed by our insurer related to litigation with OrthoClear, Inc. We have excluded this non-recurring benefit as it is not indicative of future operating results.
|
|
(4)
|
Litigation settlement. In 2010, we recorded a litigation settlement charge of $4.5 million to resolve the Leiszler class action suit. We have excluded these charges as it is not indicative of future operating results.
|
|
(5)
|
Acquisition costs and integration related. We have incurred acquisition-related and other expenses which include legal, banker, accounting and other advisory fees of third parties, retention bonuses, integration and professional fees. We do
|
|
(6)
|
Amortization of acquired intangible assets. When conducting internal development of intangible assets (including developed technology, customer relationships, trademarks, etc.), GAAP accounting rules require that we expense the costs as incurred. In the case of acquired businesses, however, we are required to allocate a portion of the purchase price to the accounting value assigned to intangible assets acquired and amortize this amount over the estimated useful lives of the acquired intangibles. The acquired company, in most cases, has itself previously expensed the costs incurred to develop the acquired intangible assets, and the purchase price allocated to these assets is not necessarily reflective of the cost we would incur in developing the intangible asset. We eliminate these amortization charges for our non-GAAP operating results to provide better comparability of pre and post-acquisition operating results and comparability to results of businesses utilizing internally developed intangible assets.
|
|
(7)
|
Severance and benefits costs. We have engaged in various restructuring and exit activities in 2011 and 2009 that have resulted in costs associated with severance and benefits. Such activity has been a discrete event based on a unique set of business objectives or circumstances, and each has differed from the others in terms of its operational implementation, business impact and scope. We do not engage in restructuring and/or exit activities in the ordinary course of business. We believe that it is important to understand these charges and, we believe that investors benefit from excluding these charges from our operating results to facilitate a more meaningful evaluation of current operating performance and comparisons to past operating performance.
|
|
(8)
|
Impairment of goodwill. This cost represents non-cash write-downs of our goodwill. During the third quarter of 2012, we determined that there were sufficient indicators such as the termination of our distribution agreement with Straumann for iTero intra-oral scanners as well as the market conditions and business trends within our Scanners and CAD/CAM Services reporting unit for an impairment of goodwill. We remove the impact of these charges to our operating performance to assist in assessing our ability to generate cash from operations. We believe this may be useful information to users of our financial statements and therefore we have excluded these charges for purposes of calculating these non-GAAP measures to facilitate an evaluation of our current operating performance, particularly in terms of liquidity.
|
|
(9)
|
Income tax-related adjustments. Non-GAAP financial information for the quarter is adjusted for a tax rate equal to our annual estimated tax rate on non-GAAP income. This rate is based on our estimated annual GAAP income tax rate forecast, adjusted to account for discrete tax items and items excluded from GAAP income in calculating the non-GAAP financial measures presented above. Our estimated tax rate on non-GAAP income is determined annually and may be re-calculated during the year to take into account events or trends that we believe materially impact the estimated annual rate.
|
|
GAAP Profit from Operations
|
$
|
85,592
|
|
|
Clear Aligner revenue case refinement adjustment
|
(4,900
|
)
|
|
|
Stock-based compensation
|
21,483
|
|
|
|
Acquisition and integration costs
|
1,271
|
|
|
|
Amortization of acquired intangible assets
|
4,362
|
|
|
|
Severance and benefit costs for bonus plan
|
2,480
|
|
|
|
Impairment of goodwill
|
36,591
|
|
|
|
Adjusted Non-GAAP Profit from Operations for Company Multiplier
|
$
|
146,879
|
|
|
•
|
to attract and retain the best available personnel for positions of substantial responsibility,
|
|
•
|
to provide incentives to individuals who perform services to the Company, and
|
|
•
|
to promote the success of the Company's business.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|